<SEC-DOCUMENT>0001193125-21-318605.txt : 20211103
<SEC-HEADER>0001193125-21-318605.hdr.sgml : 20211103
<ACCEPTANCE-DATETIME>20211103171422
ACCESSION NUMBER:		0001193125-21-318605
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20211103
DATE AS OF CHANGE:		20211103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioAtla, Inc.
		CENTRAL INDEX KEY:			0001826892
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				851922320
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-260440
		FILM NUMBER:		211376553

	BUSINESS ADDRESS:	
		STREET 1:		11085 TORREYANA ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-558-0708

	MAIL ADDRESS:	
		STREET 1:		11085 TORREYANA ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d222668d424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML><HEAD>
<TITLE>424B3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(3)<BR> Registration No. 333-260440 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>2,678,600 Shares </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g222668g01a03.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus relates to the
resale, from time to time, of up to 2,678,600 shares of our common stock by the selling stockholders (which term, as used in this prospectus, includes pledgees, donees, transferees or other <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">successors-in-interest)</FONT></FONT> identified in this prospectus. The selling stockholders acquired the shares registered hereunder in a private placement pursuant to stock purchase agreements, dated as of
September&nbsp;28, 2021, by and between us and the selling stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are not selling any securities under this prospectus and we will not receive
any proceeds from the sale of the shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have agreed to bear all of the expenses incurred in connection with the registration of these shares. The
selling stockholders will pay or assume discounts, commissions, fees of underwriters, selling brokers or dealer managers and similar expenses, if any, incurred for the sale of shares of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholders identified in this prospectus may offer the shares from time to time through public or private transactions at prevailing market
prices, at prices related to prevailing market prices or at privately negotiated prices. For additional information on the methods of sale that may be used by the selling stockholders, see the section entitled &#147;Plan of Distribution&#148; on
page 20. For a list of the selling stockholders, see the section entitled &#147;Selling Stockholders&#148; on page 16. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may amend or supplement this
prospectus from time to time by filing amendments or supplements as required. You should read the entire prospectus and any amendments or supplements carefully before you make your investment decision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the Nasdaq Global Market under the symbol &#147;BCAB.&#148; On October&nbsp;21, 2021, the closing sale price of our common stock
as reported on the Nasdaq Global Market was $28.69. You are urged to obtain current market quotations for the common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging
growth company&#148; under applicable Securities and Exchange Commission rules and, as such, have elected to comply with certain reduced public company disclosure requirements for this prospectus and future filings. See &#147;Prospectus
Summary&#151;Implications of Being an Emerging Growth Company.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Our business and investment
in our common stock involve significant risks. These risks are described in the section titled &#147;<A HREF="#rom222668_2">Risk Factors</A>&#148; beginning on page 6 of this prospectus. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the
accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of
this prospectus is November&nbsp;3, 2021 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom222668_1">Prospectus Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom222668_2">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom222668_3">Cautionary Note Regarding Forward-Looking Statements and Industry
Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom222668_4">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom222668_5">Certain Relationships and Related Party Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom222668_6">Selling Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom222668_7">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom222668_8">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom222668_9">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom222668_10">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom222668_11">Incorporation Of Certain Documents By Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should read this prospectus and the information and documents we have incorporated by reference into the prospectus
carefully because these documents contain important information you should consider when making your investment decision. See &#147;Where You Can Find Additional Information&#148; and &#147;Incorporation of Documents by Reference.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained or incorporated by reference in this prospectus. We have not, and the selling stockholders have not,
authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus is not an offer to sell these securities, and the selling
stockholders are not soliciting offers to buy these securities, in any state where the offer or sale of these securities is not permitted. You should not assume that the information contained in this prospectus is accurate as of any date other than
the date on the front cover of this prospectus, or that the information contained in any document incorporated by reference is accurate as of any date other than the date of the document incorporated by reference, regardless of the time of delivery
of this prospectus or of any sale of common stock. Our business, financial condition, results of operations and prospects may have changed since such dates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- i - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom222668_1"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This summary highlights, and is qualified in its entirety by, the more detailed information included elsewhere in this prospectus or incorporated by
reference herein. This summary does not contain all of the information that you should consider before investing in our securities. You should read and carefully consider the entire prospectus, especially the &#147;Risk Factors&#148; section of this
prospectus, as well as our consolidated financial statements, notes to the consolidated financial statements and the other information incorporated by reference into this prospectus, as well as the exhibits to the registration statement of which
this prospectus is a part, before making an investment decision. </I></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BIOATLA, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a phase 2 clinical-stage
biopharmaceutical company developing our novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Our CABs capitalize on our proprietary discoveries with respect to tumor biology, enabling us
to target known and widely validated tumor antigens that have previously been difficult or impossible to target. Our novel CAB therapeutic candidates exploit characteristic pH differences between the tumor microenvironment and healthy tissue. Unlike
healthy tissue, the tumor microenvironment is acidic, and we have designed our antibodies to selectively bind to their targets on tumor cells under acidic pH conditions but not on targets in normal tissues. Our approach is to identify the necessary
targeting and potency required for cancer cell destruction, while aiming to eliminate or greatly reduce <FONT STYLE="white-space:nowrap">on-target,</FONT> <FONT STYLE="white-space:nowrap">off-tumor</FONT> toxicity&#151;one of the fundamental
challenges of existing cancer therapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a United States-based company with research facilities in San Diego, California and, through our
contractual relationship with BioDuro-Sundia, a provider of preclinical development services, in Beijing, China. Since the commencement of our operations, we have focused substantially all of our resources on conducting research and development
activities, including drug discovery, preclinical studies and clinical trials of our product candidates, including the ongoing Phase 2 clinical trials of BA3011 and BA3021, establishing and maintaining our intellectual property portfolio,
manufacturing clinical and research material through third parties, hiring personnel, establishing product development and commercialization collaborations with third parties, raising capital and providing general and administrative support for
these operations. Since 2014, such research and development activities have exclusively related to the research, development, manufacture and Phase 1 and Phase&nbsp;2 clinical testing of our CAB antibody-based product candidates and the
strengthening of our proprietary CAB technology platform and pipeline. We do not have any products approved for sale, and we have not generated any revenue from product sales. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 1 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our pipeline </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that there is significant potential to improve therapeutics for our patients with our proprietary CAB antibody technology across well-validated
oncology targets activated in solid tumors. The following table summarizes our current product candidate pipeline. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g222668g01a06.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our business was founded in March 2007 and originally operated as a Delaware limited liability company, BioAtla, LLC. In July 2020, we converted from a limited
liability company into a Delaware corporation pursuant to a statutory conversion and changed our name from BioAtla, LLC to BioAtla, Inc. Our principal executive offices are located at 11085 Torreyana Road, San Diego, California 92121, and our
telephone number is (858) <FONT STYLE="white-space:nowrap">558-0708.</FONT> Our corporate website address is www.bioatla.com. Information contained on, or that may be accessed through, our website is not incorporated by reference into this
prospectus and should not be considered a part of this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have obtained a registered trademark for BioAtla<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> in the United States. This prospectus and documents incorporated by reference into this prospectus contains references to our trademarks and to trademarks belonging to other entities. Solely for
convenience, trademarks and trade names referred to in this prospectus and the documents incorporated by reference into this prospectus, including logos, artwork and other visual displays, may appear without the <SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> or TM symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable
licensor to these trademarks and trade names. We do not intend our use or display of other companies&#146; trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Implications of Being an Emerging Growth Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company&#148; as defined in the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. An emerging growth
company may take advantage of specified reduced reporting requirements that are otherwise applicable generally to public companies. These reduced reporting requirements include, but are not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">being permitted to present only two years of audited financial statements and only two years of related
Management&#146;s discussion and analysis of financial condition and results of operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley
Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exemption from compliance with any new requirements adopted by the Public Company Accounting Oversight Board
regarding mandatory audit firm rotations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements and
registration statements; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exemptions from the requirement to hold a nonbinding advisory vote on executive compensation and to obtain
stockholder approval of any golden parachute payments not previously approved. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will remain an emerging growth company until
December&nbsp;31, 2021. We have elected to take advantage of certain of the reduced disclosure obligations and may elect to take advantage of other reduced reporting requirements in future filings. As a result, the information that we provide to our
investors may be different from the information you might receive from other public reporting companies that are not emerging growth companies in which you hold equity interests. The JOBS Act provides that an emerging growth company can take
advantage of an extended transition period for complying with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have elected to take advantage of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, we will adopt the new or revised standard at the time private companies adopt the new or revised
standard and will do so until such time that we either irrevocably elect to &#147;opt out&#148; of such extended transition period or no longer qualify as an emerging growth company. As a result of this election, our financial statements may not be
comparable to companies that comply with public company effective dates. We may choose to early adopt any new or revised accounting standards whenever such early </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are also a &#147;smaller reporting company,&#148; meaning that the market value of our shares held by
<FONT STYLE="white-space:nowrap">non-affiliates</FONT> is less than $700&nbsp;million and our annual revenue was less than $100&nbsp;million during the most recently completed fiscal year. Specifically, as a smaller reporting company, we may choose
to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and have reduced disclosure obligations regarding executive compensation, and, similar to
emerging growth companies, if we are a smaller reporting company with less than $100&nbsp;million in annual revenue, we would not be required to obtain an attestation report on internal control over financial reporting issued by our independent
registered public accounting firm. We will cease to be a smaller reporting company as of December&nbsp;31, 2021. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock offered by selling stockholders </P></TD>
<TD>2,678,600 shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>We will not receive any proceeds from the sale of shares in this offering. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>You should read the &#147;Risk Factors&#148; section included in this prospectus or incorporated by reference into this prospectus for a discussion of factors to consider carefully before deciding to invest in shares of our common stock.
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Nasdaq Global Market symbol </P></TD>
<TD>&#147;BCAB&#148; </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DESCRIPTION OF PRIVATE PLACEMENT WITH THE SELLING STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;28, 2021, we entered into stock purchase agreements with the selling stockholders whereby, on September&nbsp;30, 2021, we issued and sold in
a private placement an aggregate of 2,678,600 shares of our common stock at a purchase price of $28.00 per share for gross proceeds of $75.0&nbsp;million. For a detailed description of the transactions contemplated by the stock purchase agreements
with the selling stockholders and the securities issued pursuant thereto, see the section captioned &#147;Selling Stockholders&#148; in this prospectus. We filed the registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1,</FONT> of
which this prospectus forms a part, to fulfill our contractual obligations under the stock purchase agreements to provide for the resale by the selling stockholders of the shares of common stock offered hereby. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 5 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom222668_2"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investing in our common stock involves a high degree of risk. Before you decide to invest in our common stock, you should carefully consider the risks
described in the section captioned &#147;Risk Factors&#148; in our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended June&nbsp;30, 2021, and in our subsequent filings we make with the Securities and Exchange
Commission, or SEC, from time to time, which are incorporated by reference herein in their entirety, together with the other information in this prospectus and documents incorporated by reference in this prospectus. The risks described in our
Quarterly Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT> for the quarter ended June&nbsp;30, 2021, and in our other filings incorporated by reference herein are not the only ones facing our company. Additional risks and
uncertainties may also impair our business operations. If any of the risks described in our most recent Quarterly Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT> and the other filings incorporated by reference herein occurs, our
business, financial condition, results of operations and future growth prospects could be harmed. In these circumstances, the market price of our common stock could decline, and you may lose all or part of your investment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 6 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom222668_3"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND
INDUSTRY DATA </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus and the documents incorporated by reference herein contain forward-looking statements within the meaning of
Section&nbsp;27A of the Securities Act of 1933, as amended, or the Securities Act, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that involve substantial risks and uncertainties. All statements other
than statements of historical facts contained in this report, including statements regarding our future results of operations and financial position, business strategy, product candidates, planned preclinical studies and clinical trials, research
and development costs, regulatory approvals, timing and likelihood of success, as well as plans and objectives of management for future operations, are forward-looking statements. The words &#147;anticipate,&#148; &#147;believe,&#148;
&#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;might,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;should,&#148;
&#147;target,&#148; &#147;would,&#148; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The forward-looking statements contained in this prospectus and incorporated by reference herein include, among other things, statements about: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to develop and advance our current product candidates and programs into, and successfully complete,
clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of our clinical trials to demonstrate safety and efficacy of our product candidates and other
positive results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size of the market opportunity for our product candidates, including our estimates of the number of patients
who suffer from the diseases we are targeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our manufacturing, commercialization and marketing capabilities and strategy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans and strategies to develop and commercialize our CAB antibodies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans to further develop our technology platform and expand our pipeline of product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential benefits and advantages of our current and future product candidates that we may develop from our
patented technology platform; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of <FONT STYLE="white-space:nowrap">the&nbsp;COVID-19&nbsp;pandemic</FONT> on our business, financial
condition, results of operations, and prospects; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing or likelihood of regulatory filings and approvals for our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory developments in the United States and Europe and other foreign countries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations and plans to obtain funding for our operations, including from our existing and potential future
collaboration and licensing agreements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding our ability to obtain and maintain intellectual property protection for our technology
platform and product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential benefits of our strategic relationships and our plans to pursue additional strategic relationships;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our continued reliance on third parties to conduct additional clinical trials of our product candidates and for
the manufacture of our product candidates for preclinical studies and clinical trials; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other risks and uncertainties, including those listed under the caption &#147;Risk Factors&#148; in our most
recent Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> and other filings we make with the SEC. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may not
actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans,
intentions and expectations disclosed in the forward-looking statements we make. We </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 7 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
have included important factors in the cautionary statements included in this prospectus and incorporated by reference herein, particularly in the &#147;Risk Factors&#148; section, that we
believe could cause actual results or events to differ materially from the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures
or investments we may make. You should read this prospectus, the documents incorporated by reference in this prospectus and the documents that we have filed as exhibits to the registration statement of which this prospectus is a part completely and
with the understanding that our actual future results may be materially different from what we expect. The forward-looking statements contained in this prospectus and incorporated by reference herein are made as of the date hereof, and we do not
assume any obligation to update any forward-looking statements except as required by applicable law. This prospectus includes and incorporates by reference certain estimates, projections and other information concerning our industry, our business
and the markets for our product candidates. We obtained the industry, market and similar data set forth in this report from our own internal estimates and research and from academic and industry research, publications, surveys and studies conducted
by third parties, including governmental agencies. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ
materially from events and circumstances that are assumed in this information. While we believe that the data we use from third parties are reliable, we have not separately verified these data. Further, while we believe our internal research is
reliable, such research has not been verified by any third party. You are cautioned not to give undue weight to any such information, projections and estimates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 8 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom222668_4"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are filing the registration statement of which this prospectus is a part to permit holders of the shares of our common stock described in the section
entitled &#147;Selling Stockholders&#148; to resell such shares. We are not selling any securities under this prospectus and we will not receive any proceeds from the sale of shares by the selling stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholders will pay any discounts, commissions, fees of underwriters, selling brokers or dealer managers and expenses incurred by the selling
stockholders for brokerage, accounting, tax or legal services or any other expenses incurred by the selling stockholders in disposing of the shares. We will bear all other costs, fees and expenses incurred in effecting the registration of the shares
covered by this prospectus, including, without limitation, all registration and filing fees, printing fees, Nasdaq listing fees and fees and expenses of our counsel and our accountants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 9 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom222668_5"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than compensation arrangements for our directors and executive officers, which are described elsewhere in the documents incorporated by reference into
this prospectus, the following is a description of each transaction since January&nbsp;1, 2018 and each currently proposed transaction in which: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have been or are to be a participant; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount involved exceeds $120,000; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any of our directors, executive officers, or beneficial owners of more than 5% of our capital stock, or any
immediate family member of or person sharing the household with any of these individuals, had or will have a direct or indirect material interest. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Series D preferred stock financing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2020, we sold
an aggregate of 140,626,711 shares of our Series D preferred stock at a purchase price of $0.51554931 per share for an aggregate amount of $72,500,003.82. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Purchasers of our Series D preferred stock include venture capital funds that beneficially own more than 5% of our outstanding capital stock and/or are
represented on our board of directors. The following table summarizes the number of shares and the total purchase price paid by these entities: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Purchaser(1)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series&nbsp;D&nbsp;preferred<BR>stock purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate<BR>purchase<BR>price($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Himalaya Parent LLC(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,009,307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pfizer Ventures (US) LLC(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29,095,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Soleus Private Equity Fund I, L.P.(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,276,145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HBM Healthcare Investments (Cayman) Ltd.(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,306,305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Baker Bros. Advisors LP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,396,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Cormorant Asset Management</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,396,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Zone II Healthcare Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,396,787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For additional information regarding these stockholders and their equity holdings, see &#147;Principal
stockholders.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Himalaya Parent LLC was issued 59,164,808 Series D preferred stock upon the conversion of BioAtla, LLC to
BioAtla, Inc., and subsequently distributed 27,155,501 shares of Series D preferred stock to Pfizer Ventures (US) LLC, one of its members. The owners of Himalaya Parent LLC include Dr.&nbsp;Jay Short, Ms.&nbsp;Carolyn Anderson Short, Scott Smith,
members of our board of directors, other employees of us and other equity holder of BioAtla, LLC prior to the LLC Conversion. See &#147;LLC conversion&#148; for more information. Dr.&nbsp;Jay Short, our
<FONT STYLE="white-space:nowrap">Co-Founder,</FONT> Chief Executive Officer and Chairman, and Carolyn Anderson Short, our Chief of Intellectual Property and Strategy and Assistant Secretary, serve as managers of Himalaya Parent LLC.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pfizer Ventures (US) LLC purchased 1,939,679 shares of Series D preferred stock but subsequently received a
distribution of 27,155,501 shares of Series D preferred stock from Himalaya Parent LLC. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Guy Levy was designated to serve as a member of our board of directors by Soleus Private Equity
Fund&nbsp;I, L.P. (&#147;Soleus PE&#148;). Mr.&nbsp;Levy is the Chief Executive Officer and Chief Investment Officer of Soleus Capital Management, L.P., the investment manager of Soleus PE, and, in such capacity, employed by a company that is an
affiliate of Soleus PE. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Priyanka Belawat was designated to serve as a member of our board of directors by HBM Healthcare
Investments (Cayman) Ltd. Dr.&nbsp;Belawat is an Investment Advisor of HBM Partners AG, and, in such capacity, employed by a corporation that is an affiliate of HBM Healthcare Investments (Cayman) Ltd. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 10 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with our Series D preferred stock financing, we entered into an Investor Rights Agreement, a
Voting Agreement, and a Right of First Refusal and <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement with certain holders of our Series D preferred stock and certain holders of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Right of First Refusal and <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement provides for rights of first refusal and <FONT
STYLE="white-space:nowrap">co-sale</FONT> and drag-along rights in respect of sales by certain holders of our capital stock. Our Voting Agreement also contains provisions with respect to the elections of our board of directors and its composition.
Upon the consummation of this offering, the Right of First Refusal and <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement and the Voting Agreement each will terminate. Additionally, the Investor Rights Agreement provides for certain
registration rights which will survive the completion of this offering, as more fully described in &#147;Description of capital stock&#151;registration rights.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Convertible promissory notes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From December 2015 to March
2020, BioAtla, LLC issued convertible promissory notes to certain investors for gross proceeds of $21.8&nbsp;million, including to Dr.&nbsp;Jay Short and Carolyn Anderson Short, Pfizer Ventures (US) LLC and Biotech Investment Group II, LLC.
Dr.&nbsp;Jay Short and Carolyn Anderson Short currently serve as our executive officers and Dr.&nbsp;Short currently serves as a member of our board of directors. Pfizer Ventures (US) LLC is a beneficial owner of more than 5% of our capital stock
and, at the time of the transaction, BIG was a beneficial owner of more than 5% of our capital stock. In July 2020, upon our LLC Conversion and in connection with the closing of the Series D preferred stock financing, the convertible promissory
notes were amended so that they automatically converted into a number of Class&nbsp;D Units of Himalaya Parent LLC equal to the quotient of (x)&nbsp;the outstanding principal balance of the convertible promissory note, together with all accrued and
unpaid interest thereon, divided by (y)&nbsp;eighty-percent (80%) of the purchase price per share for each share of Series D preferred stock sold pursuant to the Series D preferred stock financing, except in the case of the convertible promissory
note issued to Pfizer Ventures (US) LLC. The convertible promissory note issued to Pfizer Ventures (US) LLC was amended in March 2019 to provide the lender additional accrued interest upon conversion, and converted into a number of Class&nbsp;D
Units of Himalaya Parent LLC equal to the quotient of (x)&nbsp;the outstanding principal balance of the convertible promissory note, together with all accrued and unpaid interest thereon, divided by (y)&nbsp;one hundred percent (100%) of the
purchase price per share for each share of Series D preferred stock sold pursuant to the Series D preferred stock financing. In connection with the Series D preferred stock financing in July 2020, all principal and accrued interest under the
convertible notes was converted into our Series D preferred stock, and we were not required to repay any principal or interest in cash. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Lease
agreement with Alliance Diversified Holdings LLC </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From August 2014 to February 2018, we were party to a lease agreement with Alliance Diversified
Holdings LLC, or ADH. ADH is owned and controlled by a subsidiary of Bridgewest Business Group, LLC, or Bridgewest. We incurred expenses of $0.6&nbsp;million and $0.1&nbsp;million in 2017 and 2018, respectively, related to rent, including common
area maintenance, for a combined 10,440 square feet of lab and office space, and also paid certain pass-through expenses to ADH, such as utilities. The lease agreement with ADH was completed in February 2018, and as of December&nbsp;31, 2018, we had
no outstanding accounts payable and accrued expenses due to ADH. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BioDuro, LLC contract research services agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2007, we entered into a master contract research services agreement with BioDuro, LLC, or BioDuro, a preclinical research organization that provides
biopharmaceutical clients with drug discovery services. BioDuro was previously a wholly owned subsidiary of Bridgewest. Bridgewest&#146;s Chief Executive Officer is Masood Tayebi,&nbsp;Ph.D., who is affiliated with Biotech Investment Group, LLC, or
BIG. Dr.&nbsp;Tayebi beneficially owned 50% of Bridgewest. In 2019, Bridgewest sold its ownership interest, such that we no longer consider BioDuro to be a related party as of January&nbsp;1, 2020 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 11 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the agreement, BioDuro provides us with preclinical research labor and supplies in China in exchange
for a quarterly fee. The fees we pay to BioDuro are based on the number of full-time equivalent contractors assigned under the agreement to perform services to us, and such fees include the cost of labor for the contractors and lab supplies needed
to perform lab work on designated projects. The rates paid to BioDuro per full-time equivalent contractor and associated materials costs are fixed for the contract term and are <FONT STYLE="white-space:nowrap">re-negotiated</FONT> every two years.
As of December&nbsp;1, 2020, we had 18 full-time equivalent independent contractors assigned under the BioDuro agreement. During the <FONT STYLE="white-space:nowrap">two-year</FONT> period ended December&nbsp;31, 2019, we incurred expenses of
approximately $4.3&nbsp;million in connection with services provided by BioDuro under the agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sinobioway </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2015, we entered into a Collaboration and License Agreement with Sinobioway to develop and commercialize CAB antibody products in China, Hong Kong,
Macau and Taiwan, or the Sinobioway Territory. The agreement was amended several times between 2015 and 2017. In March 2017, we also entered into an Amended and Restated Master Services Agreement with Sinobioway for certain development and
manufacturing services to be performed by Sinobioway. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2018, we entered into an agreement to terminate the Amended and Restated Collaboration Agreement
and the Amended and Restated Master Services Agreement with Sinobioway, or the Sinobioway Termination Agreement. Under the Sinobioway Termination Agreement, Sinobioway terminated its rights to develop and commercialize CAB antibody products in the
Sinobioway Territory, and we are no longer obligated to present new CAB antibodies to Sinobioway for selection, funding and development in the Sinobioway Territory. As consideration for the Termination Agreement, we issued a non-controlling interest
in Himalaya Therapeutics SEZC to Sinobioway in the form of 34,976,744 ordinary shares with a fair value of $0. See &#147;Himalaya Therapeutics SEZC&#148; below for more information about this entity. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Himalaya Therapeutics SEZC </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&nbsp;1, 2020, we
entered into an Amended and Restated Exclusive Rights Agreement with Himalaya Therapeutics SEZC, a Cayman Islands exempted company.&nbsp;Under the terms of the agreement, Himalaya Therapeutics SEZC acquired the rights to 10 <FONT
STYLE="white-space:nowrap">CAB-antibodies</FONT> for the territory of China, Macao, Hong Kong and Taiwan, global rights to a <FONT STYLE="white-space:nowrap">CAB-HER2-bispecific-antibody</FONT> and global
<FONT STYLE="white-space:nowrap">co-development</FONT> rights with us to an <FONT STYLE="white-space:nowrap">IL-22</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">non-CAB-antibody.</FONT></FONT> Payments to us may include
upfront payments, milestone payments and double digit royalties, but no payments have been made to date. Dr.&nbsp;Jay Short and Carolyn Anderson Short serve as directors of Himalaya Therapeutics SEZC, and Carolyn Anderson Short serves as an officer
of such entity. Prior to July&nbsp;10, 2020, Himalaya Therapeutics SEZC was a majority-owned subsidiary of BioAtla, LLC, after which BioAtla, LLC distributed to Himalaya Parent LLC all of its equity interests in Himalaya Therapeutics SEZC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Inversagen, LLC </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;15, 2019, we entered into
an Exclusive License Agreement with Inversagen, LLC. Under the terms of the agreement, Inversagen acquired the rights to <FONT STYLE="white-space:nowrap">CAB-antibodies</FONT> for the field of diseases associated with aging, outside of cancer, and a
immuno-oncology antibody. Commencing on the first commercial sale of the <FONT STYLE="white-space:nowrap">CAB-antibodies</FONT> and immuno-oncology antibody subject to the Exclusive License Agreement, Inversagen, LLC will pay us milestone payments
and royalties. On July&nbsp;7, 2020, we and Inversagen, LLC entered into the First Amendment to Exclusive License Agreement, which grants us an option for a period of 10 years to acquire the immuno-oncology antibody in return for royalty payments in
the <FONT STYLE="white-space:nowrap">low-single</FONT> digits during the applicable royalty term. No payments have been made to date. Dr.&nbsp;Jay Short and Carolyn Anderson Short serve as managers of Inversagen, LLC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>LLC Division </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2019, our predecessor, BioAtla,
LLC was divided into three separate and distinct Delaware limited liability companies, which we refer to as the LLC Division. In connection with the LLC Division, our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 12 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
predecessor BioAtla, LLC was renamed to BioAtla Holdings, LLC and new legal entities Inversagen, LLC and BioAtla, LLC were formed. After the LLC Division, each LLC had substantially the same form
of operating agreement and capital structure as our predecessor, with certain exceptions. In connection with the LLC Division, our predecessor&#146;s holdings of F1 Oncology, Inc. common and preferred stock remained in BioAtla Holdings and certain
rights related to the application of CAB technology in senescent cell therapy were transferred to us and simultaneously licensed to Inversagen. The remaining assets, liabilities and operations of our predecessor, including all existing employees and
ownership of Himalaya Therapeutics SEZC and its wholly-owned subsidiary, Himalaya Therapeutics HK Limited, were transferred to us. Each of our predecessor&#146;s members at the time of the LLC Division continued as a member in us, BioAtla Holdings
and Inversagen and each entity has Dr.&nbsp;Short and Ms.&nbsp;Anderson Short as its LLC managers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BioAtla Holdings, LLC </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective January&nbsp;1, 2020, we entered into an Exclusive License Agreement with BioAtla Holdings, LLC.&nbsp;Under the terms of the agreement, BioAtla
Holdings, LLC acquired the rights to CAB antibodies for certain targets in the field of Adoptive Cell Therapy <FONT STYLE="white-space:nowrap">(CAR-T</FONT> format).&nbsp;On July&nbsp;7, 2020, we and BioAtla Holdings entered into the First Amendment
to Exclusive License Agreement, which grants us an option for a period of 10 years to acquire the ACT Preparations and ACT Treatments in return for royalty payments in the <FONT STYLE="white-space:nowrap">low-single</FONT> digits during the
applicable royalty term. No payments have been made to date. Dr.&nbsp;Jay Short and Carolyn Anderson Short serve as managers of BioAtla Holdings, LLC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>LLC conversion </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;10, 2020, we completed a
corporate reorganization in which we, Himalaya Parent LLC, our wholly owned subsidiary, and BioAtla MergerSub LLC, our wholly owned indirect subsidiary, entered into an Agreement and Plan of Merger, or the Merger Agreement, pursuant to which
BioAtla, LLC was merged into and with BioAtla MergerSub LLC, with BioAtla, LLC surviving, and the equity holders of BioAtla, LLC immediately prior to the effective time of the Merger Agreement received membership interests, on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis, of Himalaya Parent LLC as consideration. We refer to such transactions as the &#147;Corporate Reorganization.&#148; As part of the Corporate Reorganization,
all of the holders of our outstanding convertible notes, representing $21.8&nbsp;million principal amount in the aggregate plus related accrued interest, exchanged their convertible notes for membership interests in Himalaya Parent LLC. In addition,
on July&nbsp;10, 2020, BioAtla, LLC distributed to Himalaya Parent LLC all of its equity interests in Himalaya Therapeutics SEZC, a majority-owned subsidiary that is engaged in the development of a set of antibodies in the field of oncology
primarily in Greater China. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Series D preferred stock financing, which initially closed on July&nbsp;13, 2020, we converted from a
limited liability company into a Delaware corporation pursuant to a statutory conversion and changed our name from BioAtla, LLC to BioAtla, Inc. In connection with the LLC Conversion, all of the then-outstanding units of BioAtla, LLC were converted
into shares of our common stock and our then-outstanding warrants to purchase units of BioAtla, LLC were converted into warrants to purchase shares of common stock of BioAtla, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the LLC Conversion, BioAtla, Inc. continued to hold all operations, employees, property and assets of BioAtla, LLC (excluding Himalaya Therapeutics
SEZC) and assumed all of the obligations of BioAtla, LLC (exclusive of the profits interest liability related to awards granted under BioAtla, LLC&#146;s profits interest plan), as of July&nbsp;13, 2020. BioAtla, Inc. is governed by a certificate of
incorporation filed with the Delaware Secretary of State and its bylaws. Immediately prior to the completion of this offering, we will adopt our amended and restated certificate of incorporation and amended and restated bylaws, the material portions
of which are described under the heading &#147;Description of capital stock.&#148; Upon completion of the LLC Conversion, certain members of the advisory board of BioAtla, LLC became members of the board of directors of BioAtla, Inc. and officers of
BioAtla, LLC became the officers of BioAtla, Inc. Following the Corporate Reorganization, the LLC Conversion and the distribution of Himalaya Therapeutics SEZC, BioAtla, Inc. is a single legal entity with no
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 13 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consolidated variable interest entities, or VIEs, or subsidiaries. BioAtla, Inc. currently has a number of license agreements with related parties, including BioAtla Holdings, LLC, Inversagen,
LLC and Himalaya Therapeutics SEZC, and also with F1 Oncology, Inc., who is not a related party. These license agreements represent variable interests in entities that meet the definition of a VIE, but these agreements do not provide us with the
power to direct the activities that are most significant to the economic success of these entities, so we are not the primary beneficiary of these VIEs and do not currently consolidate any VIEs. None of the related party VIEs currently have any
material operating activities. Himalaya Parent LLC does not control BioAtla, Inc. as it does not hold the majority of the voting shares of BioAtla, Inc. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have entered into
indemnification agreements with each of our directors and officers. The indemnification agreements and our amended and restated certificate of incorporation and amended and restated bylaws require us to indemnify our directors and officers to the
fullest extent permitted by Delaware law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Private Placement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;28, 2021, we issued and sold shares of common stock at a purchase price of $28.00 per share in a private placement. In the private placement,
we issued and sold 267,900 shares of common stock for an aggregate purchase price of $7,501,200 to an entity affiliated with Guy Levy, a member of our board of directors, and 357,100 shares of common stock for an aggregate purchase price of
$9,998,800 to an entity affiliated with Cormorant Asset Management, a beneficial holder of more than 5% of our capital stock, on the same terms as other purchasers in the private placement. The purchasers of the common stock are entitled to
specified resale registration rights. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Review, Approval or Ratification of Transactions with Related Parties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our written related party transactions policy sets forth our policies and procedures regarding the identification, review, consideration and oversight of
&#147;related-person transactions.&#148; For purposes of our policy only, a &#147;related-person transaction&#148; is a transaction, arrangement or relationship (or any series of similar transactions, arrangements or relationships) in which we and
any &#147;related person&#148; are participants involving an amount that exceeds $120,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transactions involving compensation for services provided to
us as an employee, consultant or director are not considered related-person transactions under this policy. A related person is any executive officer, director or a holder of more than 5% of our common stock, including any of their immediate family
members and any entity owned or controlled by such persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the policy, where a transaction has been identified as a related-person transaction,
management must present information regarding the proposed related-person transaction to our audit committee (or, where review by our audit committee would be inappropriate, to another independent body of our board of directors) for review. The
presentation must include a description of, among other things, the material facts, the direct and indirect interests of the related persons, the benefits of the transaction to us and whether any alternative transactions are available. To identify
related-person transactions in advance, we rely on information supplied by our executive officers, directors and certain significant stockholders. In considering related-person transactions, our audit committee or another independent body of our
board of directors takes into account the relevant available facts and circumstances including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks, costs and benefits to us; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact on a director&#146;s independence in the event the related person is a director, immediate family
member of a director or an entity with which a director is affiliated; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 14 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms of the transaction; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of other sources for comparable services or products; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms available to or from, as the case may be, unrelated third parties or to or from our employees
generally. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event a director has an interest in the proposed transaction, the director must recuse himself or herself from the
deliberations and approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 15 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom222668_6"></A>SELLING STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;28, 2021, we entered into stock purchase agreements with the selling stockholders, pursuant to which we issued and sold in a private
placement an aggregate of 2,678,600 shares of our common stock at a purchase price of $28.00 per share for gross proceeds of $75.0&nbsp;million. Pursuant to the stock purchase agreements, we agreed to file a registration statement with the SEC
covering the resale of the shares of common stock sold in the private placement and to keep such registration statement effective at all times until (1)&nbsp;the shares may be sold without volume or <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions pursuant to Rule 144 under the Securities Act or (2)&nbsp;September&nbsp;30, 2024, whichever is the earliest to occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are registering the resale of the above-referenced shares to permit each of the selling stockholders identified below, or their pledgees, donees,
transferees or other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest,</FONT></FONT> to resell or otherwise dispose of the shares in the manner contemplated under &#147;Plan of Distribution&#148; in this
prospectus (as may be supplemented and amended). This prospectus covers the sale or other disposition by the selling stockholders of up to the total number of shares of Common Stock that have been issued to the selling stockholders pursuant to the
stock purchase agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not know when or in what amounts the selling stockholders may sell or otherwise dispose of the shares of common stock
covered hereby. The selling stockholders might not sell or dispose of any or all of the shares covered by this prospectus or may sell or dispose of some or all of the shares other than pursuant to this prospectus. Because the selling stockholders
may or may not sell or otherwise dispose of some or all of the shares covered by this prospectus, we cannot estimate the number of the shares that will be held by the selling stockholders after completion of the offering. However, for purposes of
this table, we have assumed that all of the shares of common stock covered by this prospectus will be sold by the selling stockholders and that the selling stockholders do not acquire additional shares of our common stock. In addition, the selling
stockholders listed in the table below may have sold, transferred or otherwise disposed of, or may sell, transfer or otherwise dispose of, at any time and from time to time, shares of our common stock in transactions exempt from the registration
requirements of the Securities Act after the date on which they provided the information set forth on the table below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in the table below
is based on 35,190,428 shares of our common stock outstanding as of September&nbsp;30, 2021 and was prepared based on information supplied to us by the selling stockholders. Beneficial ownership is determined in accordance with Section&nbsp;13(d) of
the Exchange Act, and generally includes voting or investment power with respect to securities and includes any securities that grant the selling stockholder the right to acquire shares of our common stock within 60 days of September&nbsp;30, 2021.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 16 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of the selling stockholders except Guy Levy, a member of our board of directors and managing member of
the ultimate parent of Soleus Capital Master Fund, L.P., has held any position or office, or has otherwise had a material relationship, with us or any of our subsidiaries within the past three years. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2"><B>Name of Selling Stockholder</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="6" ALIGN="center"><B>Shares&nbsp;of&nbsp;Common&nbsp;Stock&nbsp;Beneficially<BR>Owned Prior to Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center"><B>Number&nbsp;of<BR>Shares of<BR>Common<BR>Stock&nbsp;Being<BR>Offered</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="6" ALIGN="center"><B>Shares&nbsp;of&nbsp;Common&nbsp;Stock&nbsp;to&nbsp;be<BR>Beneficially&nbsp;Owned&nbsp;After&nbsp;Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;Number&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;Percentage&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;Number&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;Percentage&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Soleus Capital Master Fund, L.P.(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,500,553</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">267,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,232,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Cormorant Asset Management(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,172,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">357,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,815,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Pappas Capital(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,415,141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,379,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HBM Healthcare Investments (Cayman) Ltd.(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,430,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">178,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,252,096</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Great Point Partners(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">844,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">714,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">129,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Ikarian Capital, LLC(6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">200,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">196,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deerfield Partners, L.P.(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">464,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">464,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Sphera Healthcare(8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">214,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">214,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Monashee Investment Management, LLC(9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">178,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">178,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hudson Bay Master Fund Ltd.(10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of: (i) 1,115,817 shares of common stock held by Soleus Capital Master Fund, L.P. (&#147;Master
Fund&#148;); (ii) 1,167,378 shares of common stock held by Soleus Private Equity Fund I, L.P. (&#147;Soleus LP&#148;); and (iii) 217,358 shares of common stock held by Soleus BA SPV, LLC (&#147;Soleus SPV&#148;). The numbers in the table above do
not include 14,871 shares of common stock issuable upon settlement of restricted stock units directly held by Mr.&nbsp;Levy, of which 33.3% of such restricted stock units will vest on December&nbsp;7, 2021 and the remainder will vest on a monthly
basis over a period of 24 months thereafter. Soleus Capital, LLC (&#147;Soleus Capital&#148;) is the sole general partner of Master Fund, and Soleus Capital Group, LLC (&#147;Soleus Capital Group&#148;) is the sole managing member of Soleus Capital.
Soleus Private Equity GP I, LLC (&#147;Soleus GP&#148;) is the sole general partner of Soleus LP and the sole managing member of Soleus SPV, and Soleus PE GP I, LLC (&#147;Soleus PE GP&#148;) is the sole manager of Soleus GP. Mr.&nbsp;Guy Levy is
the sole managing member of each of Soleus PE GP and Soleus Capital Group. In such capacities, these entities and Mr.&nbsp;Levy have the shared power to vote or to direct the vote, and to dispose or to direct the disposition, of all of the
securities directly held by Soleus LP, Soleus SPV and Master Fund, as applicable. However, each of Mr.&nbsp;Levy, Soleus GP, Soleus PE GP, Soleus Capital and Soleus Capital Group disclaims beneficial ownership of the shares held by Soleus LP, Soleus
SPV and Master Fund, respectively, except to the extent of their pecuniary interest therein. The address of the foregoing entities and of Mr.&nbsp;Levy is c/o Soleus Capital Management, L.P., 104 Field Point Road, Greenwich, CT 06830.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of: (i) 991,531 shares of common stock held by Cormorant Global Healthcare Master Fund, LP; and (ii)
1,181,115 shares of common stock held by Cormorant Private Healthcare Fund II, LP. Cormorant Global Healthcare Master Fund, LP and Cormorant Private Healthcare Fund II, LP are each managed by Cormorant Asset Management, LP. Bihua Chen has voting or
investment control over the shares held by Cormorant Global Healthcare Master Fund, LP and Cormorant Private Healthcare Fund II, LP. The address of the foregoing entities is c/o Cormorant Asset Management LP, 200 Clarendon Street, 52<SUP
STYLE="font-size:85%; vertical-align:top">nd</SUP> Floor, Boston, MA 02116. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 17 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of: (i) 1,309,026 shares of common stock held by A. M. Pappas Life Science Ventures V, LP; and (ii)
106,115 shares of common stock held by PV V CEO Fund, LP. A. M. Pappas Life Science Ventures V, LP and PV V CEO Fund, LP are managed by AMP&amp;A Management V, LLC, the general partner of A. M. Pappas Life Science Ventures V, LP and PV V CEO Fund,
LP. Arthur M. Pappas has voting or investment control over the shares held by A. M. Pappas Life Science Ventures V, LP and PV V CEO Fund, LP. The address of the foregoing entities is c/o Pappas Capital, LLC, 2520 Meridian Parkway, Suite 400, Durham,
NC 27519. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board of directors of HBM Healthcare Investments (Cayman) Ltd. is comprised of Jean-Marc Lesieur, Richard
Coles, Sophia Harris, Dr.&nbsp;Andreas Wicki, Paul Woodhouse and Mark Kronenfeld, none of whom has individual voting or investment power with respect to such shares, and each disclaims beneficial ownership of such shares except to the extent of any
pecuniary interest therein. The address of the foregoing entity is Governors Square, Suite <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">#4-212-2,</FONT></FONT> 23 Lime Tree Bay Avenue, West Bay, Grand Cayman, Cayman Islands.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of: (i) 513,998 shares of common stock held by Biomedical Value Fund, LP.; and (ii) 330,004 shares of
common stock held by Biomedical Offshore Value Fund, Ltd. Biomedical Value Fund, LP and Biomedical Offshore Value Fund, Ltd. are each managed by Great Point Partners, LLC. Jeffrey R. Jay and Tavi Yehudai have voting or investment control over the
shares held by Biomedical Value Fund, LP and Biomedical Offshore Value Fund, Ltd. The address of the foregoing entities is c/o Great Point Partners, LLC, 165 Mason Street, 3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP> Floor, Greenwich, CT
06830. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of: (i) 174,731 shares of common stock held by Ikarian Healthcare Master Fund, LP; (ii) 15,361 shares
of common stock held by Boothbay Absolute Return Strategies, LP; and (iii) 10,052 shares of common stock held by Boothbay Diversified Alpha Master Fund LP. Ikarian Healthcare Master Fund, LP is managed by Ikarian Capital LLC. Boothbay Absolute
Return Strategies, LP and Boothbay Diversified Alpha Master Fund LP are managed by Boothbay Fund Management LLC. Vikram Khanna has voting or investment control over the shares held by Ikarian Healthcare Master Fund, LP, Boothbay Absolute Return
Strategies, LP and Boothbay Diversified Alpha Master Fund LP. The address of the foregoing entities is 100 Crescent Court, Suite 1620, Dallas, TX 75201. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 464,300 shares of common stock held by Deerfield Partners, L.P. Deerfield Mgmt, L.P. is the general
partner of Deerfield Partners, L.P. Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P. Mr.&nbsp;James&nbsp;E. Flynn is the sole member of the general partner of each of Deerfield Mgmt L.P. and Deerfield
Management Company L.P. Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and Mr.&nbsp;James&nbsp;E. Flynn may be deemed to beneficially own the securities held by Deerfield Partners, L.P. The address of Deerfield Partners, L.P. is c/o
Deerfield Management Company, L.P., 345 Park Avenue South, 12<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor, New York, NY 10010. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of: (i) 92,149 shares of common stock held by Sphera Biotech Master Fund LP; and (ii) 122,151 shares
of common stock held by Sphera Global Healthcare Master Fund. Sphera Biotech Master Fund LP and Sphera Global Healthcare Master Fund are managed by Sphera Healthcare US Inc. Michelle Ross, as portfolio manager, has voting or investment control over
the shares held by Sphera Biotech Master Fund LP and Sphera Global Healthcare Master Fund. The address of the foregoing entities is PO Box 309, Ugland House, Grand Cayman, <FONT STYLE="white-space:nowrap">KY1-1104,</FONT> Cayman Islands.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of: (i) 43,255 shares of common stock held by BEMAP Master Fund Ltd; (ii) 38,181 shares of common
stock held by Monashee Solitario Fund LP; (iii) 24,888 shares of common stock held by Monashee Pure Alpha SPV I LP; (iv) 7,193 shares of common stock held by SFL SPV I LLC; (v) 5,618 shares of common stock held by Bespoke Alpha MAC MIM LP; (vi)
8,651 shares of common stock held by Monashee Managed Account SP; (vii) 5,541 shares of common stock held by Mission Pure Alpha LP; and (viii) 45,273 shares of common stock held by DS Liquid Div RVA MON LLC. The above entities are managed by
Monashee Investment Management LLC. Jeff Muller has voting or investment control over the shares held by the above entities. The address for the foregoing entities is c/o Monashee Investment Management LLC, 75 Park Plaza, 2<SUP
STYLE="font-size:85%; vertical-align:top">nd</SUP> Floor, Boston, MA 02116. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Hudson Bay Master Fund Ltd. is managed by Hudson Bay Capital Management LP, its investment manager. Hudson Bay
Capital Management LP has voting and investment power over the shares held by Hudson Bay Master Fund Ltd. Sander Gerber is the managing member of Hudson Bay Capital GP LLC, which is the
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 18 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
general partner of Hudson Bay Capital Management LP. Each of Hudson Bay Master Fund Ltd. and Sander Gerber disclaims beneficial ownership over the shares held by Hudson Bay Master Fund Ltd. The
address of the foregoing entity is c/o Hudson Bay Capital Management LP, 28 Havemeyer Place, 2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Floor, Greenwich, CT 06830. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 19 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom222668_7"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholders, which as used herein includes donees, pledgees, transferees or other
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successors-in-interest</FONT></FONT> selling shares of our common stock or interests in shares of our common stock received after the date of this prospectus from a selling
stockholder as a gift, pledge, partnership distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their shares of our common stock or interests in shares of our common stock on any stock
exchange, market or trading facility on which the shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying
prices determined at the time of sale, or at negotiated prices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholders may use any one or more of the following methods when disposing
of shares or interests therein: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicit purchasers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a
portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exchange distribution in accordance with the rules of the applicable exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">short sales effected after the date the registration statement of which this prospectus is a part is declared
effective by the SEC; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange
or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated
price per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any such methods of sale; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other method permitted by applicable law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of our common stock owned by them and, if
they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of our common stock, from time to time, under this prospectus, or under an amendment to this prospectus under
Rule&nbsp;424(b)(3) or other applicable provision of the Securities Act amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus. The selling
stockholders also may transfer the shares of our common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the sale of our common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or
other financial institutions, which may in turn engage in short sales of our common stock in the course of hedging the positions they assume. The selling stockholders may also sell shares of our common stock short and deliver these securities to
close out their short positions, or loan or pledge the common stock to broker dealers that in turn may sell these securities. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial
institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 20 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The aggregate proceeds to the selling stockholders from the sale of our common stock offered by them will be
the purchase price of our common stock less discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of
our common stock to be made directly or through agents. We will not receive any of the proceeds from this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholders also may
resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act, provided that they meet the criteria and conform to the requirements of that rule. The selling stockholders and any underwriters,
broker-dealers or agents that participate in the sale of our common stock or interests therein may be &#147;underwriters&#148; within the meaning of Section&nbsp;2(11) of the Securities Act. Any discounts, commissions, concessions or profit they
earn on any resale of the shares may be underwriting discounts and commissions under the Securities Act. Selling stockholders who are &#147;underwriters&#148; within the meaning of Section&nbsp;2(11) of the Securities Act will be subject to the
prospectus delivery requirements of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent required, the shares of our common stock to be sold, the names of the selling
stockholders, the respective purchase prices and public offering prices, the names of any agent, dealer or underwriter, and any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying prospectus
supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus. Selling stockholders may sell the shares of common stock in compliance with the provisions of Rule&nbsp;144 under the Securities
Act, if available, or pursuant to other available exemptions from the registration requirements of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to comply with the
securities laws of some states, if applicable, our common stock may be sold in these jurisdictions only through registered or licensed brokers or dealers. In addition, in some states our common stock may not be sold unless it has been registered or
qualified for sale or an exemption from registration or qualification requirements is available and is complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have advised the selling
stockholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market and to the activities of the selling stockholders and their affiliates. The foregoing may affect the marketability of the
common stock. In addition, to the extent applicable, we will make copies of this prospectus (as it may be supplemented or amended from time to time) available to the selling stockholders for the purpose of satisfying the prospectus delivery
requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We shall use reasonable efforts to keep the registration statement of which this prospectus constitutes a part effective at all times until (1)&nbsp;the
shares may be sold without volume or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> restrictions pursuant to Rule&nbsp;144 under the Securities Act, or (2)&nbsp;September 30, 2024, whichever is the
earliest to occur. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom222668_8"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The validity of the shares of our common stock offered hereby is being passed upon for us by Orrick, Herrington&nbsp;&amp; Sutcliffe LLP, San Francisco,
California. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom222668_9"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, has audited our consolidated financial statements included in our Annual Report on
Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2020, as set forth in their report, which is incorporated by reference in this prospectus and elsewhere in the registration statement. Our financial statements
are incorporated by reference in reliance on Ernst&nbsp;&amp; Young LLP&#146;s report, given on their authority as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 21 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom222668_10"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other documents with the SEC. Our SEC filings are available to the public over the
internet at the SEC&#146;s website at http://www.sec.gov. Copies of certain information filed by us with the SEC are also available on our website at http://www.bioatla.com. Our website is not a part of this prospectus and is not incorporated by
reference in this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement we filed with the SEC. This prospectus omits some information contained
in the registration statement in accordance with SEC rules and regulations. You should review the information and exhibits contained in or incorporated by reference into the registration statement for further information about us and our securities.
Statements in this prospectus concerning any document we filed as an exhibit to the registration statement or that we otherwise filed with the SEC are not intended to be comprehensive and are qualified by reference to these filings. You should
review the complete document to evaluate these statements. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom222668_11"></A>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC allows us to incorporate by reference much of the information we file with it, which means that we can disclose important information to you
by referring you to those publicly available documents. The information that we incorporate by reference in this prospectus is considered to be part of this prospectus. Any statement contained in a previously filed document incorporated by reference
will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus modifies or supersedes that statement. Any statement so modified or superseded will not be deemed, except as so
modified or superseded, to constitute a part of this prospectus. This prospectus incorporates by reference the documents listed below (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-38890)</FONT> and any future filings we make with the SEC under
Sections&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus and prior to the sale of all the shares covered by this prospectus, other than the portions of those documents not deemed to be filed. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1826892/000119312521092812/d149588d10k.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2020, filed with the SEC on March&nbsp;24, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017021000192/bcab-20210331.htm">May&nbsp;12,
 2021</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017021001443/bcab-20210630.htm">August&nbsp;13, 2021</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017021000359/bcab-20210615.htm">June&nbsp;17,
 2021</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001826892/000095017021001919/bcab-20210928.htm">September&nbsp;29, 2021</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of our common stock contained in our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/0001826892/000119312520313813/d75718d8a12b.htm">Form
 <FONT STYLE="white-space:nowrap">8-A</FONT></A> filed on December&nbsp;9, 2020, including any amendments or reports filed for the purpose of updating such description; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Any other filings we make pursuant to the Exchange Act after the date of filing the initial registration
statement and prior to effectiveness of the registration statement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may request a copy of these documents, which will be provided
to you at no cost, by writing or telephoning us using the following contact information: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BioAtla, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Richard Waldron, Chief Financial Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11085 Torreyana Road </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">San Diego,
California 92121 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(858) <FONT STYLE="white-space:nowrap">558-0708</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 22 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>2,678,600 Shares </B></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g222668g01a03.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:400pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>November&nbsp;3, 2021 </B></P> <P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g222668g01a03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g222668g01a03.jpg
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M 0$! 0$! 0$! 0$! 0$! 0'_P  1" !' (T# 1$  A$! Q$!_\0 '@   04
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MS'X[>G?B3=2MP@*1BJ])B[>OI\A#U*/D(>8#X#Z#Q,06"""#W]1]OS'S_/\
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MZ*&SG+;9*[5*NR7EK':)J*KT!%-A(#B2FII\A&Q;! 53II L\>N4&Y!5433
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M8JNQ@VW#?^/A\A'S#S ?MV$=""P5((/;MOM^?_H?+[?EM9''?6!7<'R/V_\
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M'( T9%5UW5ANK 3VBVQ!!!(V(.X[<,VQRM]DS!VI\=D^8^2L7*<K065;.U[
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M%FCYHJ@^CWB:#YBX;O&Z"Z?4<T,5B*2"9%DBE1DD1O)E8;$?:#Z@@@@[$$$
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@*\UBS8E>>Q/-(Q>2:::5FDEED<EGD=F=V)9B22>/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g222668g01a06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g222668g01a06.jpg
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M5E=SD['A(C,U4G62EK*TTM;Q(S2DU3(V-T*U)')TMB5#17:EL\3_V@ , P$
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M9M5I()<M!8F7<^SFVT^ROA\(+W\IW/?C=X1ZB<;M7?JIY+&52PQA!?CFM[_
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MQN#_ /<QSX_9Y8_YL]XO"].9&[53A.^,:+>59S_:A]U[^3I_HS>4GTXW!_\
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MZ8EI3VG,R:1%2E5EGS,VC56JJV/JUHQJ':AYD8TM' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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MH>ZT&B35\FJ/./<-&]"XB:MOY_[T^V[<"X6VSX $$,5N0+KQ&WC16LU'Q:4
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MAHOUC\Q[DV5W,L_Q*6]&/7W_ %]_\^^./C_#1?K'YCW)LKN99_B4MZ,>OO\
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MA;4@UZ-;,RSG*[BH\+68R=DGO=&DXSD:Y8D&)+S$?8[SZYC,< < < < < <
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M7/K(-"(Q-4+^R00+96L9K8CZY:G>JLOO^[O@J@'S$\VUS606*;QP,NC$.\;
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M@,%C*%>.I0'#J%2.*K2HTJL45:I4K115ZU>*.&&/"/#''H#G< < < < < <
M< T<,'H>(MJHJ<(>MN7%$XM>-X3Q<)UPRS78J#$J:_3M@J"PSD;DK&)EO=FW
M6?4>^)A$]>K/48-<5 %FSC9*REPM1:+7EK7KWP3JZ>C"!/.P7QO,;,%9"71D
MF9+%'O55&9O-8%M@Z/>CB?LUYF<<^MDZ]'PZ4IKVN5*PM@(D4<>E[LWFF,,-
MJ\5NZ]<5^R@.0L^C+"JFQ->N(S98KH0BN=!KI"LM5T<&19H+7D=NGR%5T[3S
MC"X18:E526.X<M8;5%4EQBJ[(U^IB!=:%/PGGBC5Z]&WH\"WH"^-?^"S-K[S
M';?*\?OFY9KO9=GLO"-FFFL"KVOE:!B!-6'1QEV=;#D:&G9B%,?J[YFUZNUA
MRF/C"L]!K-5@+6OJW4YZ]>O(#P+>#3P11MHZ7K>1&0W0[K?VZQ+>O8M2A;I>
M@R;AVOEN0U5V.YD6JS-LA!%--]D$TTL,%UM<-)C.36W-I9^L*E^!7INO[VSK
MU41:&]%&@8L@1H<FA,;+(UB36.1<CTJ%&H@G$#O+<>ZF11UXK$6QCZ1->M66
MVNU/I4Z)'\: ]?ZODR+',7FK4U>_AMY, 6OUZ(X?./ A;F],H*HK3J5JNPWK
MVK*P+<7<J1XF-/BI4O!-G9/9&4&JEQ[>2?3R-(OE8[Q\>!HX,$%6D0L%E;U7
M%:T6_EKYJ=X$U6/1X42/C9LG1$^RABD<V'M>CMJ@W:BUE4UNH:O+U1*8J7A6
MJ-7=MS)74A+"G*Q:@PQ=MI"4BPO[RT8YUY3& ZLKS)LY>7K6["X$@^*'A&$\
M6R%N_4?"3WG@ODU@#*6"1CKX8/=*A1U*G+?Q,$\R<8C4VL_'[5=3*6*O8FJ:
M>@/6K$TS'V,!Q5KUZ]\$3*7HU0&J=9^/8/3>P!ZYN+1AO6)F]N%_46_:<+_A
MK/5VTM:#0-M-*;@"W$]3ZQVVU,852474>M+12U/A1%3QVY\^[6]5QS1?-M!?
MO7@$KX>.K9H?O:#V3F;M>&%"R>8YLC2J&9V4P;8F/8:MK#N_37UH\4-,IW+O
M$1?JSPB+W0;LE-!A)-,K>BX4W R(U!K<ZG/7DB['<JT'6Y-R#',(+J6/E'5!
M>5]-:GU)0L$,L,>H?G8Y8US>/2=1=Y95A1$,-L]_*Q]CKBNSF2F]5\X-9_I)
M/1UM/F.5IXCBD@T=')5L9S5):\=GXVI\/X&'7RFM9C^!G\9W\/\ T/A=>K'K
MK+K\O7/FVE9T&U)6+)S"*L".UK8J-<K'KJ18<9JHY-BZ\)G+LJBW+=S3033>
MUN#[2*SM*+"6 VU[*B3423?-0&S,LBSDA-V;&2) 5S>,19:=C(VKDU8FJ_8U
M$74]^+UMOYX&_P"]A_W1SB_8#8?P<SXRXV#[<SA?^,:/>0H?K(_%ZVW\\#?]
M[#_NCCL!L/X.9\9<.W,X7_C&CWD*'ZR/Q>MM_/ W_>P_[HX[ ;#^#F?&7#MS
M.%_XQH]Y"A^LC\7K;?SP-_WL/^Z..P&P_@YGQEP[<SA?^,:/>0H?K(_%ZVW\
M\#?][#_NCCL!L/X.9\9<.W,X7_C&CWD*'ZR/Q>MM_/ W_>P_[HX[ ;#^#F?&
M7#MS.%_XQH]Y"A^LC\7K;?SP-_WL/^Z..P&P_@YGQEP[<SA?^,:/>0H?K(_%
MZVW\\#?][#_NCCL!L/X.9\9<.W,X7_C&CWD*'ZR/Q>MM_/ W_>P_[HX[ ;#^
M#F?&7#MS.%_XQH]Y"A^LC\7K;?SP-_WL/^Z..P&P_@YGQEP[<SA?^,:/>0H?
MK(_%ZVW\\#?][#_NCCL!L/X.9\9<.W,X7_C&CWD*'ZR/Q>MM_/ W_>P_[HX[
M ;#^#F?&7#MS.%_XQH]Y"A^LC\7K;?SP-_WL/^Z..P&P_@YGQEP[<SA?^,:/
M>0H?K(_%ZVW\\#?][#_NCCL!L/X.9\9<.W,X7_C&CWD*'ZR/Q>MM_/ W_>P_
M[HX[ ;#^#F?&7#MS.%_XQH]Y"A^LC\7K;?SP-_WL/^Z..P&P_@YGQEP[<SA?
M^,:/>0H?K(_%ZVW\\#?][#_NCCL!L/X.9\9<.W,X7_C&CWD*'ZR/Q>MM_/ W
M_>P_[HX[ ;#^#F?&7#MS.%_XQH]Y"A^LC\7K;?SP-_WL/^Z..P&P_@YGQEP[
M<SA?^,:/>0H?K(_%ZVW\\#?][#_NCCL!L/X.9\9<.W,X7_C&CWD*'ZR9E^''
MH'-::MV6#V;N$@5>>U6ST0"J)B07.MRE8<\,Z)(E3@%02$,Q\F'<U:I8GRI?
M*/BYYZ\W<,?6/TK,T1L:RYELY EW/F(:*D)T:*Z,V$Y=L1C'(B)$1*HUZHJM
MJJMHZCCA6GOLE^%'A L"8T9M:U).5LF=>Q9^%9$@VSHT]"95?:<U'9%B1'R;
MW:KXLNU6,C*QC8NO#16.[&E*G6'U8*=.&.O6KQXQ1118XX8888===8]=8X]=
M==>KKKK_ &<Y.:^G*X X X X X X X X X X!@SL7R-\4U+9[;HPXLTV(OM6
MPYT-]]"=9%#ZY>L+>A:+*5$['N5%NV.V,RW]/#U%>S21<C8XQK)1-&$0, 0@
M'PE=4!#LFY_1L/;\2;[>HE9I8=<+2YO"+:4_BRQ,!(21-['9-3]R"+$.NB#^
M/V2N.FCK(ME'9@Z!P1['0]_&3Y)#)&JV_P "W;?#YZ^$$F^0#WXV1J^N6%G\
M=PN^=5^2KAK$[>=**IK,TM$SKG-K[6&JV<N.<R@HZ\M!=?;0M9?I+89C98];
MK3-ZXH!X>J))N_R8UY^O?7O@P&";1\-YV;9/F;5\9-L-TLE%1MG1!<9H:1?J
M:NV.*U\SZUV2+'S&QQAFNN4VLDL5JW6IL\SN@1P&X+Z2HK,I/XVVOV=;JYJ#
M/'48#Q>V)LO<6E^O#U1U^7U<:6MCDL6#7NHYQ;!.V6MK(JPXQP*5\_.O'RP4
M(ZD!85LJ@V3O7;X-*]#X:K:5H5GAYN7DI=X/-W@9*E_&CQV8"N9T[HK41@U(
ML2)694GKM3O$,E"95*HLZQW;LBI)_F*PDG"Z?8%]9]4YU<C; 30YBI<JO(!)
MXT>.TV:O)-HK44TB2<S94^6;7:G+*LL,G87*0V#DD%99C2LDJVN3R7JN4=B2
MRO K6<G=@..EK 7TL:WUZE6\[Z<C**K=E"#UJ2XNKHD-9D71)AB818+.<?4K
MR9!QQYN:C5$=EEW4JE60Z0@APM%KTLX%Z< < < ^4OS6\[L!P#<-X9F4I7\9
MJY7RJ8_&R/Q^*;C=Z.DUW>6F=P;C;8=HBE37]G:1E-CTTT(YM:2\Q)/6E=MA
M.,5\2=)P4,:"_P!$*EFY8Y393X,.ST=:42STDG349).'.2DU-1?;+(<!9E\+
MVI$A/AP=5TND5'O<Q[J4AZR*JX%X0)>T9W3!T'0F4TN72B#8%G1-(IO1O2"P
M+ D76+'G;498LO:"Z025I2\Y:*1X-L.D'2\I"CRT%T58LWQ41D-N%_G+'L>/
MR;?^]H'4ED.61FO2*Z7UH+G!:WL:O+:V42NG8T$!:J4;8!1JZKNI]4*#NUL"
M(FI#C1*262<%NU-\FV/;'NA']LO@Q'JV YCI=JLEUEW2\)TJD!BHU60DEG0D
M8Q4UFHE'5<BJN0N#A;)70^RTL:6M&4EF1K5@S<"V(S9FUVVS M>?@6^MJ33(
MD5DU/OMN'/OF)F&]8,=[N,@(R Z&QN)//F'.#M!?R9K^D'RU_L;J;_&W?F0^
M#_\ 'VG]%*_OQC3?V7_Y*T'_ $A;?\-9QVYN9--%QP!P!P!P!P!P!P!P!P!P
M!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P
M!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P##?97@=XZ;9:G!N<0;?/?>;)DF
M?&C-BNP=9F86+78O5)UHKJP\U  K,)=# KP$C>P']XVZX2KE/!G)<,Y%+5>N
M>T%I2>C7\5,Q, +%9<(1$-*K1D'P;&<XZEW"AMS8V[J$Y&#HMW%?N#W[;FRK
MP^U9QDF'TVV[3I95\:(7,6JO1]R>9 2:5\.=-E<?'2/K/8 B/Q6!4EW34:]L
MER Q@QU$"'5H\BL8PK7P9+TRT$K@+)$YC=NS![IL=W/U5/&(KJJW\^W[01MC
MZ-_QBJU =,./V6NX+#N.?UN5?W#L<5: FEY=G4TRH)LP,7QM,%K]=N$1B$%C
MRZI*N!4K9%80WB%FUG 3OISQQUYHLYLM@1;;SG=VTVD7MT@:'YJ;1MQM+VY[
M1(Y0''R5VH*NV\98*&>=".#K .,#!H<8Q@<=5K 3UP!P!P!P!P!P#Y2_-;SN
MP' -\7HU-;^36S-'"X1K%X\@_&P3O6PKP$-D^,03RJ?@6R=D5TD22G#*.**T
MW%%=+0CU2$HSN+(@ID>0^*2R8E[J=]1\RL"!:$Q)M1KY%D@V<6&CIBSVVE&9
M,3"0F.5L)(,184-R-AHZ)&B0(/X*5>M%IK3PNVOH=8VD<9T:4TIF=+H^C39U
MT.R=,9G0FS)FR+(?:,>$R8GUM.2ASTW =%G70).SY.U+07C5:R WC$UM:_G9
ML85M'RFV>QA")PJ+%R*R!4OGU-(0[<V&KDU?UQEC23-=1X)ZR AD5LH%@,*[
MFRHKL0R&_8L$<;<V?P+9CMF;2F8C'/<UJPX*.?"@P57VO!AR]T*!_A0V(L*D
M-K:TAZJ.5754RYP;65&L;0NQI28@RT"-&;.VH^%*SUHVG#:MLVA-6LG&6A:S
MG3\Y-.2=1TY,1]5(LVZ,Z$QD%8;4Q%Y\PYT=H+^3-?T@^6O]C=3?XV[\R'P?
M_C[3^BE?WXQIO[+_ /)6@_Z0MO\ AK..W-S)IHN. . . . . . . . . . .
M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
M . . . . . . . . . . . . . . . . . . . . . . . . . . . ?*7YK
M>=V X!?>N]H;(U$RU7'5;ZWZZ:J7JZK,*4Q%5HMA'UGCGE!G=$6JD\U67+'K
MJ>I-E)5L8>N.>&2/++'O]H$Q,2L1(LM&BP(B;'PHCH;MM:5:J*J8HM47E13Y
MMK6-9%NR;[/MJS)"UI*)_P <K:,I G("K141R0X['M:]M:MB-1'L7\)KD5$4
MY6U]KO>[WPULW9AB!A>&/ 7T>.0!08'(K,($T0E:]<H+@T2+S)3T1U;(F1QI
M8W2]_P"4%2D]LG<MVY[,S,:;C/F)AZ/C1-77>C&,UE:UK$56PVM;K*C4UG4J
MYU7.57*JK^=B6)9FCEF2]CV/+NE;-E%C>U99TQ,S*0&QX\28?#AQ9N-'C)!;
M$BO2#!6(L.!"U($!L.##APVQUS\#ZQV@OY,U_2#Y:_V-U-_C;OS(?!_^/M/Z
M*5_?C&F_LO\ \E:#_I"V_P"&LX[<W,FFBXX X X X X X X X X X X X X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
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M.UF#?58XJ7<+]PO%(5$INE,7F2\0KI-CYN8:T,BQA1N*YIGG7[,_M!L(X X
MX!JW])#Z1.;P?UY;.K">*=7+J^%@HACUR[0$S5KY"O6NRS6*'7=KJ2"M+G+!
MCAU\'.7'KK/OX'7?K^=:UHMLJSYF>="6/[6AI$XE'I#6)5[&4UU:_5IKUKJ.
MV4I><[X-M!XO"+II8.A\*T&V2MMS4652T7RKIQLJL.3F9M'K+-CRRQD<DLL.
MB1X=%=K56E%T<_C+.]/T;-4_2EM_Z>< ]\R%W&B>4&^IFY7:%SWSG2G[)1OZ
MB'XRSO3]&S5/TI;?^GCWS(7<:)Y0;ZF.T+GOG.E/V2C?U$/QEG>GZ-FJ?I2V
M_P#3Q[YD+N-$\H-]3':%SWSG2G[)1OZB'XRSO3]&S5/TI;?^GCWS(7<:)Y0;
MZF.T+GOG.E/V2C?U$/QEG>GZ-FJ?I2V_]/'OF0NXT3R@WU,=H7/?.=*?LE&_
MJ(?C+.]/T;-4_2EM_P"GCWS(7<:)Y0;ZF.T+GOG.E/V2C?U$/QEG>GZ-FJ?I
M2V_]/'OF0NXT3R@WU,=H7/?.=*?LE&_J(?C+.]/T;-4_2EM_Z>/?,A=QHGE!
MOJ8[0N>^<Z4_9*-_40_&6=Z?HV:I^E+;_P!/'OF0NXT3R@WU,=H7/?.=*?LE
M&_J(?C+.]/T;-4_2EM_Z>/?,A=QHGE!OJ8[0N>^<Z4_9*-_40_&6=Z?HV:I^
ME+;_ -/'OF0NXT3R@WU,=H7/?.=*?LE&_J(?C+.]/T;-4_2EM_Z>/?,A=QHG
ME!OJ8[0N>^<Z4_9*-_40_&6=Z?HV:I^E+;_T\>^9"[C1/*#?4QVA<]\YTI^R
M4;^HA^,L[T_1LU3]*6W_ *>/?,A=QHGE!OJ8[0N>^<Z4_9*-_40_&6=Z?HV:
MI^E+;_T\>^9"[C1/*#?4QVA<]\YTI^R4;^HA^,L[T_1LU3]*6W_IX]\R%W&B
M>4&^ICM"Y[YSI3]DHW]1#\99WI^C9JGZ4MO_ $\>^9"[C1/*#?4QVA<]\YTI
M^R4;^HA^,L[T_1LU3]*6W_IX]\R%W&B>4&^ICM"Y[YSI3]DHW]1#\99WI^C9
MJGZ4MO\ T\>^9"[C1/*#?4QVA<]\YTI^R4;^HBK OY2WMC$R*[9?&?7LR_T1
MI_/<81P8ZYC(3\HC^<.A<MZM9I8$?DOQO=/*W#)6^4=1_'X]Q_"YYPN$J6=$
M8V+9,:%"5R)$B,G&17,:JT5R0UEH>NK4OU>,979K(>I/^P0MJ#)3<6S^$2SI
MV>AR\5\G)S&CD>1@34RQCG09>+.-MF<659%>B,='25C\4CM=83T2AVC/'KR%
MU3Y1:I6MR::9J[,FLM?UXY=? A+ BT.$?9):91G4DDH=B#RRXPD!T^677JRA
MN4YK8VW2NV<CR\S FX$*9EHK(T",Q'PHK%JUS5WHJ+5KFN1',<BM<B.1431N
MW+"M?1JUY^P;>L^8LNU[,F'RL](S3-2- C,I@JLB0XC5;$@QX3GP9B"^'&@1
M(D*(Q[ILY^Q\D< < < < < < < < < < UV[N\F-)ZB=]O:J>_'-O)8;5 ]7
MCMRJ UC:!^19$OWI'0L0>\-O.=8Y<HEYMJZVU%6;MCA 29=["&UKHYW26ZN-
MZ^'9NI5?O\((LH[6\.-A[!TX[&?#,K8.O=)UV&D;+N:FUTULXK8>M5J\Q[ "
M"P2F=9=GEVU3CU$+6B;*F+!Y<MNE77*B*82A4TO1=K^1>;;2[PTNO^VH,NM6
M"M >4NL1&])-++W=7>*H7LFZC\G+4[42#-2W4UVPA7+J'LK6N9EDU?&*1NEF
M0OUK0 =2#SR34ZL<.,V OS/QH\>I#])JDTGJ^1D&NI38] Y(E ,R=-]-W@94
MPW5[>5'N6(^3,+"V<NDL,NK%@\ "G),\BPNE<@ J4&@-'UL%F.OJ/74&"8!6
M591PB4 >&*TMIE5@I*0$'UC2ZZ&"5JFULU4'0I_%5AD!\Q%4CBP(6NI /*70
MFDIE$X@2ZFU[FDLV"M&P*G:F%Z E^D80N $K*\,ZI]59Y5$*GJ8Q9GRC^.!5
M%H%$+DJ]"J/Q %I0>(OBU5FIV*OCOIBM*.!DEFAW7URJ08TEXP,:@I8+5CB%
MX1P#285Y<0U^G%AC#;$LYL9/A)1(V8) +F1?'K16L6+-NUWJ+7B2U2!,UJ1C
M65,,'-R+\L2Y#.%D)TJD5S,;8Q4%?.U3RF[ALS@AEJQA)9JQR] 3%P!P!P#Y
M2_-;SNP' ' ' ' .T%_)FOZ0?+7^QNIO\;=^9#X/_P ?:?T4K^_&--_9?_DK
M0?\ 2%M_PUG&ZK?G@];V)Y+Y[^PWFFH52<GXZ,&80RFMA%D%D/'UU)-XF4$9
MJ[T4-?25V^S;E"D\W?4CU.)I=6+"U8'&.X;];)U;NGO7W;*><T7+70/1^LNG
M!3723/*R Z<WWKN!;VI4VSKL(;6-GNTCJP/S4W+XG7[?JQJ$TFKK96W82=;!
MR97:"-K5K7>Q;%%%JC2\Z]>MU^(+>6?1WNJ1V=[U9Y>@P[*!UU:7UIM+:G&,
MK*F[!-ZH\9-)O.P#L-/9(81=J]*/C'3)IJYT+"R*#HW72Y ZQT%@4'GM4NNV
M<_)55IOV@RMU#XH!=6L?C_L; ^@P6M+:%VYJ0W83$DHNBGNGLIGT\UCV^T;:
M=B[ :8LEZOJNY(0D:6UX(LI9Q+LEAB'2]6*Y!6Y>=47HKF#,C(L*PN5QV1,?
MB0MP]6*M'*Y6QN6:_?4G?4]>KW)U/-#WU%+WU+'AEAWU')_I?Z&7J@/SHP([
MLV:?10=W;I34J]RKU>K=V:DY'OKH?!9@^-^-@FO]Y8]4HY<<,[7>774&,GKZ
MX!4> 8L>57CVK^0PC4@MQ?"R$ UUMV/8UNVOL!M.8C>7W+=I:]@" '9;9U4Z
MGE8YMA8,,!H=<O29X )1$XNS3*6)JUKMYTIO1?,#$,!Z-MP7D@AJX5OI3QUQ
MLA1TZG;NBCTCU4:VFAI<Q:D#G->G!NS:@-!97I7RH#=@$2RL]T[#7B8?5<>N
M73<@JJ^WKR94![*?HYFY%OM+!I;R6P2]IM8'R!'6&-R0"NT1J7WO7R&M;HIM
MNITLWM4=4U:R 1=B=%/6UBS6 ;#)"5AX,@JA]9BKVBK7O7;DIUP!L!T'KS#4
MVG->ZXCNJI*-07JXG FEASH)<)XQS3R]$J8]H=]DL>5HA\;\L+DCKVT%C1F8
M@9OE9[)"3K" E[@'CGE\''++X.67P<>\O@X]>O++U==]_!QZ_)Z\N_5ZNNO7
M^7OU=< U!:[](X[1#=7;%VL#UN:UKNG23%O_  ":FZ+8/WC>D*VQ]2I[)ANV
MRQM1$4RU5$%M6R<=F04)U]("*ZW=UVBJ';,=:>.JFWF5$QKMO3FN!>39Z5C5
M:A1%&2&J=I60)S3S;N0:3']*EK+H. U3LC>8 ,7J1L'<BT<>-3:WM-:Z-9,Q
M1*:-@!X?-\E' P4%$2OW]^GV@JC!Z1NEK@RXB-EZJ;JY4#NP7K6RJ+N2E?9$
MD!/JKQ<<31YC^0/9Z)LJ F/R5 #B32NU ZH,ZLCU\G/5+2KI)[4V=Y5V\ZY;
M+\A4X?2!+=W6?DULQ?TJW#CFF-"E-^#Z!VRJQ];.6PQS<J,-R[(JQ-A("(86
MC2C-7M_/5'Y</6+@PO7IRRRVQE,B55$Q6@*:S>>-[0 *?K=I/4V\6#%IJ0S9
M^*=Z3JTLI<ZPE'B)ERU\W.3,?'Y!I'05)6,BV$JO&5TLO'C,Z+.;'A[4!4H/
M22*-LI.OUM,[*[8"[)46-<4;1C7%"GL"[+MK:NG;MK$Q:<8Z"B/'L6H&B_W*
MUYC[%X5.(ZH5;!6_&,Z=?."CV/2B:^R),XT-I+=1_(%9U^#&$AE1,MK#,Z/;
MAX_I6*<)>Z+;=U]-?&%O(Y*RB+5FRXN'*0AF*"2\P;I6)M-IWMBKT5R^P&<6
MHCNXS]!LL[C0UK7]NNY%J:4-7FCIIF)(T4520,9/V(H<*@\Y9DEM5[HZG-9@
MBRJ]2X2=1S1^N E.>E3M2TY[-2M8G'6,[@^:>"*:6A;DJ6A\EJG))AEG5L9T
M+UVEG/!EA+E4N6JV67<-B7#,#D\ < < ZK?\H)_^A*__ +P#_P#\ZOSB^E_Y
M"M+_ .+_ /Z(!L![&7_K/H'^EIG_ ,1:AU.^:_G= . . . . . . . . . .
M . . . . . . . . . ;+_1<^8OD3XM^1:L%TD!,[0#[4.B5IQT;4GRZK/D4
MLW<4%X7G+WW4 -0*"2Q;&M4W450?5PMQ'LY%^4A%WSG0BV+2E;0AV= A1)R3
MFGUC0$7_ "VQ'3<-SE1L-&)3C6N5&Q41&_C.+5-2_98<&>@ND.A$]IK;5H26
MC.DFCTJK;+MN*U?_ ,8=^&^7T<FX,%KH\\LW$UFR#X3(LQ9\5T28:BR?MR&_
MZ&D$F4T$,N<,E?.6*.3.O+W%E+!EGAUEE#)E!)-!E)%WWWAGW#-+%WECWW')
MGAZLN\WG4F>W@#@#@#@#@#@#@#@#@#@&(3?X2:7>7O:NQ&*YLFRP;B'IU!NB
M@V.S5!$&6N;PDQKF\NBZ]J.LO74)B"U&A5R&]15AS-.4-]UIKQDM+= ]NLO"
MG2^H=CK>T$6?8@UA5T*KK:C2M[$9BJ];4Z^9J]/2*AB5NS7(3%65@+.QNS+E
MU(8=K$3*0^/(4Z4E<"?M9:X5=1(:UK9)J6:*HI4.QH2I;NV"-F"IW8GM=X37
M;><EBQE\=8ER^'+GEEZN^L?7ZL>N 7UP!P!P!P!P!P!P!P#Y2_-;SNP' ' '
M ' .T%_)FOZ0?+7^QNIO\;=^9#X/_P ?:?T4K^_&--_9?_DK0?\ 2%M_PUG&
MX3R>\3MA^1N[G,/EU&,7IVSQ.=!CN865AJ!4D!!$^1(QC6!81_5'%"96)?=V
MKVG(JK"$LUKHEV&VOAX2QPS4LF]>O7OFBYC2/]'#O@7KR9 L:]TJT,K#IU&U
M4I[;*..58GXM.R5MG:#@Q;>TZ'P0)Y1 MSF=0VT5)/1;*9946H")UO?[]D5\
M$P4+7S^&O(NQ>_?X,1<$'H[=SHS=M+9XU&TQNHOL7[]G*AKEWS5DY=%FMV^2
M][9^M+CTV*2 ->-QH1E%C ]MZ'L5G.9IS *E$J-[H$9PC6BK7'DKX$1-G3]P
M)LN>'_DS?\2T[QD -.L%!,9ZH=7VDG,JO;9^P8BWL@SL/;!.-C2F[7XQD2MG
MC\)->U--JBKKVLE*;W;'!7B&JK4\95;Z@@F/P#\G2)!:#.JQI9W8%;37CIHI
M+\DK['./<M84?&[R0W&YAMJIP2VL-+94<VC3S.@8VA5)UI2SO \B)8&L@%Q[
M-SE5*4O1*JNY*<O)LKA?S O>SXD[=14+8(:+2&JI]B3$#=(%Y+)A4L;W3M9Z
MV)Y6(NR=<.S:,I*@J<,&UW)3HNFQ"KDP,_LJ25H)5"[65*1,C8+X?#WDKUPH
M#=7R PM\U?&@UY0AM"J@^X"H!4GR ';%=;9Y=3G&&%5I:BW"H=]T4_8"RW);
M,1R87-?QC',(.U3AJY6RD/>%T=5]=1:5YT\Z Q/E\1/,'6UNQK?1FW&>CJ1-
MUK,@ZN-E=Q2B[E?7PGQ@RUPM(MI)BUR670^TXO(N.ON+K=0^CGV,4,<$D51H
M#*]9?K*\WVX\O*N&WGV@MFAXB>9+!>TXR[,."#)+7S+I@F5B";3=1;(<#:^\
MB-N-\M4ZRF3+@PEK%/6KHJ7+(,T_-@2P>"S4J)*S-2'W)8"IB/%3T@BUK@4E
M)^\PZS5">-X7YO&U60I7QJ^1]1:#ZV,*X^P,$U(1>H[20.*M8BP/QJ61.WCT
M;?3'T+0N*]E>NQ%Z]<0;'O&A9VJGZ645[=)S-@V)2L-,I2]*9ML4]820<#Y)
M2"63Q&:V3,65Q0M@@$Y J48"\\@W+LLUMY'JTTF("=^ :*GCTE7BWIJAMIHI
M^)@?'/8OC>O^2>=E?%H0N[Y$)&P7W-7'B&B>-=AE(FK>NS<&US=1ES.1QJL[
M55Z[O]@"5NQ42JI?1:T[W6_P]\&8[MOOT?U)L8_;Y42K;8J"<D&^;O\ CNPL
MW1&K7L+>MS>LTYNJZX)T7RRMY[B"J#*BI1,[8"TF\J+("8*<+-#2G7KT Y^&
M_? O;+8FTB*ZI-C0X-%:W1(-?CZR6>UK8AXZ;TN,IOS&PZ]^0ZUV(RG],E]9
MAZ#R27V0]80*"Y1PM5ZJ_!.IGUZ[+P<C4ODQI=I\M=T^*ZKK=/6SFK5V@&O-
M@VRJP1M,&=:FW9*-<51&5.K5&,LZ;&D@#BC3'=$GTO:UAW7TB>V#G;W7KU\X
M(W6WWQRNK3,P'/#;6REXDZX;=S1+NTNU#5QD;B_Z[V#+IQQMTM)A5^=O'%-A
MN DLNH]Q2&-#6[]"JU8R$!R%PE6[;_#YE2Z_O K;#Y3>CY+PXI# H4V7-HCJ
M@S"'-XI['9KD5XGM#80NBE.ZI'JDA*#8B.XTMYZI*+31I%+SCUF?K4)NS54O
M<FS[@4(/Y=>!.;JTG"R8DJ82PD:F:@F\R&G;D:N]I..FZ_DPA1D76-"PKKUU
M.2DG-I4$QL+56"K82J]E>#UB@\95Y:+LY]^S(&4?WXWC]#KTIL\LW&5A27W7
M/735(XH.P4\XF.6*[7;80CHJ,JP+9U.6\N7PY<99/"*%(I48%O(?9LY, C&Y
M >&K?+?4^\6Y;7M/D9G@,;2V%TO-T-(P&&!ZHL%I)F#C^ZYH12L$+K$#WHMV
M8ODW>$0FZ%:@!3*%D73(<>!A%J;TKG6ZQ*+WKW0$K R['/ZH!K%$=N!8(*=:
MUM1"W/L&)?:WBBO6*RML5/$Z6*8MVOKHB4B+Z95BSE>[ANR?%>2I2M^RO?N5
M$V857'D7O R-.>?FN!WC(0\B ZLPM)8(NV3C/ID,65)]AIW8DX66629NPP-2
MT ZTNG@!JI:;,<[8\I'2B[7(#5\D+&W/%+U1,090Z]VA0?F#;BM@-G$G=.[%
MQU\Q59K&%J*WD12$S8ZX;'SX10]YT3"@^ 9Y8\XNLAYF,P'[EM=C.[<[S@ZX
MGI\5T^PC*M0"%*FK><X;+"J*H6B%G/&.Y7RDRQ@J132Y8QX_Z6>76'JPQ_+E
MWUUSCND\M'F[(GI>7ANBQHLOJ0V-5$5SN.A.HBN5$K1JKMY#-? !;EDZ.<*>
MB%MVY/0;-LJSK2C19V=CZZPI>&^S+0@M>_BVO?JK%BPV51BWN2MU5.K']R7:
M?NW>_HD>_8.88[%K?[F1_P!:%Z0[4NV"X&?G L3_ %OJ@^Y+M/W;O?T2/?L'
M'8M;_<R/^M"](.V"X&?G L3_ %OJ@^Y+M/W;O?T2/?L''8M;_<R/^M"](.V"
MX&?G L3_ %OJ@^Y+M/W;O?T2/?L''8M;_<R/^M"](.V"X&?G L3_ %OJ@^Y+
MM/W;O?T2/?L''8M;_<R/^M"](.V"X&?G L3_ %OJ@^Y+M/W;O?T2/?L''8M;
M_<R/^M"](.V"X&?G L3_ %OJ@^Y+M/W;O?T2/?L''8M;_<R/^M"](.V"X&?G
M L3_ %OJ@^Y+M/W;O?T2/?L''8M;_<R/^M"](.V"X&?G L3_ %OJ@^Y+M/W;
MO?T2/?L''8M;_<R/^M"](.V"X&?G L3_ %OJ@^Y+M/W;O?T2/?L''8M;_<R/
M^M"](.V"X&?G L3_ %OJ@^Y+M/W;O?T2/?L''8M;_<R/^M"](.V"X&?G L3_
M %OJ@^Y+M/W;O?T2/?L''8M;_<R/^M"](.V"X&?G L3_ %OJ@^Y+M/W;O?T2
M/?L''8M;_<R/^M"](.V"X&?G L3_ %OJ@^Y+M/W;O?T2/?L''8M;_<R/^M"]
M(.V"X&?G L3_ %OJ@^Y+M/W;O?T2/?L''8M;_<R/^M"](.V"X&?G L3_ %OJ
M@^Y+M/W;O?T2/?L''8M;_<R/^M"](.V"X&?G L3_ %OJ@^Y+M/W;O?T2/?L'
M'8M;_<R/^M"](.V"X&?G L3_ %OJ@^Y+M/W;O?T2/?L''8M;_<R/^M"](.V"
MX&?G L3_ %OJ@^Y+M/W;O?T2/?L''8M;_<R/^M"](.V"X&?G L3_ %OJA<*M
MX];U=3HU;5]1;%,&2UVJ/I5:ZB<QQ[L7)\*\/=FS+2CJTJW4DF/<]V[-7J58
MNLY[,\4.&<F/Z0=$M((T5D)+.B,UW(U7Q'PFPV(JT5[U1ZJC6I>M$5:)<BK1
M%].T/9'<"]G2,W.NTYLV;]JR\6.DI)0IR-.33H3%>V7E8*RS&Q(\942'":^)
M#AZ[D6)$APT<]O=@]%7Z*Y4\-E2KLC8M:@S>0+.-B[+&/B^IJ2=0M1QRR+"Q
ME)UUEA!AG\'HH5^!%:,6(^LLNH:456K#F>P+ E+!E$@P42),Q$19J:5M'QGI
M_P!K=NI!8M>+AHO*KG*YRJIU:<-'#1I%PQ:0K/SZOD+ D'Q8>C^C\.*KI>SY
M=RT68F%35;,VG,M:UTW-N:FQL" V'+PX<--TW\W\W/O&&1P!P!P!P!P!P!P!
MP"P]H7=D#=?M=[4 %5:-F51,TJ8ONYR^M*A4SUG'U#5-G!8PS?'T^XNY<_C:
MPZ?*27"*#+.M'+G:A O:ME8RK5\KD<,-O*"+*U%7FSL5XK'<>/<\<$\D-:2>
M'"7X6,4TE>#.3#K'/*&+++O#$#3+OBEZ0"]L_P X'C4[DWK6MM4"G;[G@;(@
M1)WG6#[P\"77US4.I_N-WX&$OAY&L55AK;)&;>CNP,2^?0NT@M\&:&3RNNWX
M;5V^#DNQJ#G,F\?*,ALO32$S7=M)K>+\AZR@49]::&V#'X_M&I1-C3#>::=A
MX6%/;9WLVXAV)JTDI00/(!+I&9FS:1PPJ])]&G3E.]T]_+[,023Y*>3GF9J]
MCVS8UMJ5>8D!3VTDZV5;LFE]N/AW($;\?JVUC&R"$:<]"96Y:SV7)7TI6C40
M5?YA-FXR)&^7(+]A9.*<_)7?LZ+]P(2;O.CR@-[,,:D&Z^H""^9:UW$HK6NM
MM3N:^.1]@^*],F2@V?(1A3W^FP -PN5]B"KB<',:W& J@YUQANV;GJ@/W#S!
M\ZSE\/>EUI86:ZANIY ,-,5XR;BLJCVK=Z WBQH*]$486F-\[[^Z6FJ 0\U9
MINMHJ#"UHW<]'(/9O!6*Y>?+K4'JW9Y:^D$"A":4G:UPF=R'C*[NUML5/%_:
M_5-8VC8T3LK;R;422AC93NOF[HXRM+^HIEIJ7.K9'9%SY?7KD.K'>NZQ*52N
MR[EY[^]D"]Y/*OS!5RT=(7JTBXCC.RG+L,6*:/W;/'LP?6:=0A *4H1TR^.&
M@ZQA:;'1\'.>U9VE8%T%NX)L5+785F,#Y=UZW[@93>*FY_([930UBMZ:^#J@
MC[G*._J%X*@O:5W0(,.R-X)!U"/VW!E8ZK$?#@]:I3K)9%PK4](=L*C!< R4
MY!)HF!F[P!P!P#YJ7FWXB[&\,=^NNIG<"3I@H396[K5JGK3?,[TA279,U\Z(
M(]X?);D_0Z6K6/4X)I9PIO"X+N]8SP>O/ =KV7'LF=BRT9CD9KN=+Q%1=2-
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M^/O2/&/] +QO^JG0_P!GN/<BR>YUG>)0/0CWQ>$'Y<:9?M/;/KX^](\8_P!
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MXVGAL%_.L ,35EO5J=F>0.KV00LG<DK0=$350D2CABBN8180$V\ < < < <
M< < _._7UUWWUUZ^_5WZNOYO7W_5Z^_R=>O@&CQ3](H[IVJ<]J-NQ4_;FQ#
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M .W1@==^->PD(Z*8R"JH&06=./;S(O& ),(,*8$Q$\9V@(+U;B^%JI1+]O\
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M;1:0L>>63;,PYBU)Q\K9RQ%LVS6VI:L[:<.R;-6,UD59"RX<VV1E7/9#5T*
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M'^7 'R2K_N\/_EX?Y< \\(((^_A811X=_P!>.&/7?_/KK@'MX X X X X X
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MG#M&S+2>QJ-6;99[9*+(18FK1'Q8,.8F(#HCJQ'04EH6MQ<!C6]H;F0S34<
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MXYX998Y==]_:,3G(X X X X X X X X X X X X X X X X X X X X X X
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M'@>/%&DUB+IP4\2K&<FZL&#E_J###JR4)SXXS7;DOPI[$G76<N>7?7KX!7N
M. 48:O P]]A*BA-&@2;"=8TRWJM>.*T<*TP@E;J7R4V/76=JS6 @@XF"23OO
MN*B.JP8>K"/KK@%9X X X X X X X!K8V+Z/B#9XZ,.>V'F.KU_+/;WE*),
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MP8!HCVH<:L\F)"QC2"7YUZ_;W@932>0EO/Q!<]NK&S])O6QE'1!G84;=3A8
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MMR7A1(\Q8UK0(,)JOBQHUG3D*%#8FU\2(^"UC&IRN<J(G*IE-S]CY(X X X
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M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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M5T=J3:-#'?VO-+-XD#X0ZKWPRZ^1>D?KLEN=W)'\ZTPV4G:E$U82A?&D+9;
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MBBCPQCCPQQQPQZZZZZYR<P$JJY555555:JJWJJKM55+IX(. . . . . . .
M. . . . . . . . . . . . . . . . . . . . . . . . ?*7YK>=V X!N
MI]%TG:=<]9[KJ,"Q9(/(LR%*MQFYIWR+VR-SU&/F7C$2Z,RT,/+P ,RUT*YC
MW.LT0![S,#*AJBTQCHQQ^3#EFCL*5BR\VCX:NCM<UT5RRL]--65:L-Z0V^TV
MN1BN<V*V*D35=$8YB0WM1KS7KAFM"W[/MC1Z)*SK(-FQI>8@2$O#M_1.PXR6
M]%9-P%FXW9-%@.FD@0YBSXUGODW1X4G,P)A\Y*1EC2S5U /<JK.\.4R)2(#D
MB9K894T>7SRD*T%60O<S7J1.3.6?*0A5$=TX+N>4TV65F.7+N63OOO/OB\;B
MEC15@HYL%8L3BFOO<V%K+Q:.6_\ "1M$7;?4SQ9K9UMG2#;3B0HMI-DI5MH1
M8"(V!%G4@0TFXD%J-:B0GQTB.AHC6HC%1$:FQ+5Y^9[IV??Y,W_21Y8_V(U9
M_CSCS(7!_P#YBTOH9?\ ?BFG/LO_ ,CZ$?I*V?X61.W7S)QHJ. . . . . .
M . . . . . ?G?7KZ[Z[_F[Z[Z[]7??7?Y?_ +>O5WU_[>N_7U_LX!JXN>C[
MV<0T2+\:2'D8G%M,) K7B=KE0-^. (Q\6B:_.R$*5?9)J]L.4\VN^06$,!I.
M*,3U/5'RA\F#I;LF2<\\%5:W]/W=5!8-+T28:JJ6Q>>YXLW(BG=(Y;8E?5M:
MNP'%N'Q$T=XQ5UDY-*]6R)1-G/:8DVD85+1C.B5]L2:EW+5M5>W*^5;\$P3O
MJNZMP/:Q>BH]J6:FT7=JH"]/]S!VU_F$U_HJ\CJZ?8;,=_XX6M1@@VXHZZ2M
MV>M\6?;A4.9NV+YFKPSW"PNR:FF&KN?IY,%NOW7@V'Z]\<=*ZY3EA0"ZLUE!
M"MT56/Y50UZK"_EQE1IYUQ3')7@H2]X%ZUBR0O4KDEBS=H6"5W.&[W+9L330
M$Y< < < < < < < < < < < < < < < < < < < < < < < < < < < < <
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M^1]"/TE;/\+(G;KYDXT5' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' /E+\UO.[ < [#?@AJW:P+2H2
M!*UMYDU4C:>:3LB&Z&L>&XU$9F59/*$UB$>5WL*R+#PC[L!15J:^D9D:'W9!
M*T,'W!#E1#6L:W-['EYEDHQ(,"U4@S/%1T5BV4V#$B0WPJHU\XQ7M9&CPH:,
M@ZS?;38;6N9&1JTU7X2[:L29TAF7VA:^@#[1L5MHV0^',-T_C6G)R<Y*S[6.
MBP-&8W$19FS+*GYV)-6CQ,3L?CSD:+#CV?%F&*_0ML6U=O;!>[I+)CR(W')G
MM7\G#XGIMRNV#=Z6UDT]5HH*_M'W/G)V;^3PPP_.?=KXJ*./X.'7#8ZN='C*
M[C-98L17<;3C=97N5>,HB)QE?^.B(FM6B&S-DLAPK+LV'!242%#L^39"20UE
MD4ALEX;6))*]SGK*(U$]KZSG.XG4UG*M5+-Y^1[YV??Y,W_21Y8_V(U9_CSC
MS(7!_P#YBTOH9?\ ?BFG/LO_ ,CZ$?I*V?X61.W7S)QHJ. . . . . . . .
M . . . . :3DCTLCCLI-JYJ/CYZ]K1(*>VL6N;3$5)$Q,;UL%9$K9U=#@E^Z
MS[)7#.KFBELL(,20]]K-7*Q=)J#<3( Y-0JI1=N-_>Y.O?V G_5_G+L+<U\+
MTA(FGN@:LG:=:=U&&W:S8EQ5+.VMG[#U?DOZXK-.K Q.8RHW]8LDQ09L@6CE
MK;7)2UET.H,,1,C14IMZX>!<07O7\P')FTQXS-Z5KU8^Z5Y1[++ZS4@C6V%!
MJ(JW0"WMEW+&6-C&K9$O;@Z5M1&HQ(D>%CNEV,H*&8V*=/Y62KD3=MZ43S@E
M?8&_6+7GAYLGR3++*@1;-;:,V%M0DH*CUTV)1 _K]3.'K8 ._P!0-1S)!KA
M+)1C,] *UN"*7+N<7';@EK=$2JHF*T!A2Y>E6'J&S+@2SIUMK:P"/6*JW.;6
M$=M=M:4 ET\FOO;^R:Z?5)>8J:F);'08'82,M>&N-1\;NP\)K(D?9B[4^R[I
MV=_E_N"7O'GS/V7Y"7E8\'UQK!:UKC-I95?K+/M6^(?8WO;_ (YZ]\A?@Z^7
M+";V)9P8*ELU96:%.\>%L#9/79C ^M2J@8*QEU_OUPQN&QSD X X X X X!
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M\-=/##?U*,7J)ZX'VN4'L-\I=W.KU9%C7-MV=!%P'L$<:6QY-(+4N0&?O '
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M1TZ-&G6BQQBKU:E6&*O7@CQQCBBCPCPQZQQZZZR\=9I4. . . . . . . .
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MC_8C5G^/./,A<'_^8M+Z&7_?BFG/LO\ \CZ$?I*V?X61.W7S)QHJ. . . .
M. . . . . . . . . . . . . . . . . . . . <6S>IT^NN[5J"OUW_-W-
M+A'UW_[.\^^N </Y^"?\6'_WN'_KX ^?@G_%A_\ >X?^O@#Y^"?\6'_WN'_K
MX ^?@G_%A_\ >X?^O@'MA+B[&?4<!&G-)W_-A'8BSR[_ /9CCEWWWP"H\ <
M< < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
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M1%<]MCVPYC4:R88U%23G%1D&T(3%<U&3+(\"'OWYRLUO' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' +/(["0 ]X@,+/">+)";R<+*#R+
M,%I7AI/8A?I?U^.(5+-V*Q3O/1[OH(G5+,<=AG+]]#0D=ZYWU#P"@*6[=,O]
M1OOHFW-9.E'7UBS4?;JF^*S%42+5.*U/;KMUD05N0K<U6"C=FL1&,Z><,5.U
M))CCA7F[P _?NVZ9^0VBGW7-8_-E(A$)ND?;Y5^0U"LZ7ELF$9:M_.WR>N0F
MUUCD_14I9,+,B7CDTX1]@^N[_0'H6=[Z/=4D]LM-W+JEMURJQD96=_6=AJ)Y
M)7(A%+$B6D/-0HQ;!!XQ8_/&^1S(7Z^-*EEC:L]Q0=]2=@2E))'%'G++)A'%
M'AE))+)ECA'''ACWEG)GGEWUCCACCUWEEEEWUCCCUWWWWUUUZ^ 1")\A] 'Z
MRM=!;ST\:IO++<3$FV)V:E$:SBX#^H>[ZHK3TS<T3"RT>K-?NX"$YVRE;J>'
MN:KA\;A\(#C2^2?CI#1M%)M^Z5B&TG/'7-PC+M-&CHU-A98R9XH=JWF=ZKUW
M/+"*7/%7EDP-]XQR9=4>^L,N^@)JX X X X!\I?FMYW8#@#@#@#@'9]_DS?]
M)'EC_8C5G^/./,A<'_\ F+2^AE_WXIIS[+_\CZ$?I*V?X61-^OECYC&/'Z\T
MB%/7U1Z+J*UX^&"\%ZRT=996O)/R2&Z U_5'"4I2=FP]W5[%;&8B(Q<6S3%?
ML@U\&OAB5\[WU7R>B5Z%7H2IHJ0NI^DV5>E0ZR;5U:06I%NB>F<%]8Z*6C X
MP"WF;TU2OL-3:B]J'/7H:_4""W&YGN'#7YI3'E:-([1AD['V+\ZY@DY@])=X
MTJN1N^;IOE19'1T88GV!?7R":R-A/1*3Y$B$D&9&-%N2\QE=5.@4K1OVZM-0
MRFIW:4K5#U!3EMVB[J^"M/M!4.O2%ZL.+#.:1$W8[%*I:O9]CM=G($*R6=?]
MB9=PC@PMZ-!CYC*6!I8-'O\ 0$L6O*;^KV:%$:PX'.P+,KDC,Z]>D$5+GI+J
M_MR^#]@:MO*" K7&D.M%Z!#L^U/1=46?'TE\G!@ZT4(^OVS'_(-4#KM<T4#Y
M8U+@B\4GIR63=1=O7[<@9E:TW[GL#9QS71!&8T>U5U@J;,%5&R*M39,8R;OL
M/7S6NGQ8^V5%U""N=1J5JN3$'3(-C$M0^Z%O6:M62U8@,B^ 1?MG8$^NP"]?
MH"X#9AFV1K'7X@5/8SK=32/3V!7#!/'..*;.3I45[QYSLU\,.LK%)=M0]20_
M#^-P Q?8/*9_BV-N2HL:TUS<UCH-UFU>W,;9M*95V&5>K&B@&\?CTI-E2KPD
MJ!ZH-ZJO?)96VFQFYI6(T,&YCUVM"<M-Z53IIY@8_P#W_P#N4?JUM:[WCGKD
M@YJ&@=/^55=<5]JMQ865T_N8!M@M6H59JVE9V&ELP<=U3?"%1':_84JH8[AL
M(HZ4UY<8X*JFSG54Y$V>&FQ<=MP-KH8E3-"!1JA)7GI%QM(G3GJV*]RO-4(5
MH[E>6O<JYR5K4$L<V,D5FO+)!/AEU-%GGAGCEW 5+KKKKU]]====]]^OOU=?
MS]^KKKU]_P!??JZZZ]??^SKKK^;K@'[P#4_KGTDI<P5V@2?M%VQ&L4DGL@)0
M>50J:A@G:TGR)QT(MHYDYMM1U+J29IV'EW==0G2IMMFHAQJ^=%,<HPST-KWK
M3DV[-Z5W D7#TFWC)\U4V*85LFHE$$^@\P.<Z31^8,Y2OCWWY5"USJK <F8I
M6^_JJ,F7AJP ):&!P9:$62\%VZ'[*J+6G+]E] 70Y^?6J==]F(7_ %AN9/O@
MDP"W.-%@6$JGTKUF_9QS3".$/E^W[-<S(.VP F(-?NCC1-4ZIE1QLNQB@$)@
MD)@(GVQZ3?QS74KYYKH38_%*FI73>:FK6(4:C'D:U"F;"V7DN%L)V@F:72HH
M=J=M*CW6HJG4CK(%C=4V5@*R!:)"HE51,5H":4OS;6&AVEUW8UT_3NG;LQ +
MP)9%4#EE'5UHCK0#=;-BRS%A]:M7'L^T @8E429GB>'J F8IQW0(HJ5IP'C#
MY4M=K9&SY.T37H_0VG=D-.IG%S/[/["[1G:E#3U/;ADXM:_OJ<:Z6!1PW8 5
M47V_5F:Y1@(N^-*$$/[K36FSG_M]M01]5](OXT[$&4Q=I'V$;$.%J9,<Z]I;
M1F$$MB26RDO34LCD2#O)M?/*Y)KV@GU.O8H@[XW0[#*2QIR4AI[L;*=>N_ %
M:->DNT NJ*D\'%_:PM;V%/<O:]O7E<%6]O$,>%R8+FSE.*5LQD++40GXB>!:
MCZQVR1GO#1XK6UXB1IU)E.N> +QJ^4VRMAY6RNA?'-G?DD48WXFDFYM;%G7]
M>X]Z1)FE7 8N#\YSY$H";'];.I0L]<KB\8B5+*[>JT@O<16=]V\&62248S:>
MKF7!;P3FHJ!%$6%3P*0&^ELO<I0V+X/,O6AAJD)1=B3.G/:JX9599H9.ZTUB
M#XNQ*!=' ' .N1Z?/^B>7_[LQ_Q"ASXFD/Y'M/\ 1EI?P48REP+_ /5+@[__
M 'YH;_\ 9+,.F=S7([SAP!P!P!P#*+P^\:]Y>4F\E'7F@JI&NXUB-$_.Z5;%
MT8/UN/&7:\N3N7.T>NK >$-8ZAFI2U<OG.X3^240\5@G8K0Y\DT8LFTK2M*$
M^SXCY5)5[(L:>1%U99M=B<D2)$36:V"MT1-;7I"1ZI@_A[X1]!M M!K1@Z92
M<K;ZV_*S%GV;HC%<U8MO15:FMKW.?)R,F]T*--6HC4=)/2"LJK[0?*08GTDM
M<+S$IH"6KMS?<V TKZP$#L3P1'T15YN-#AU>J28;0P9A'0H3%K<4MW.G5ZRC
MK]S?%=2S=X]S9[!HE$1%555$1*K2J\ZT1$JNU:(B8(B'2E$<U\1[V0VPF.>Y
MS83%>YL-KG*K8;71'/B.:Q%1K5>][U1$5SG.JJWIRG@. . . . . . . . .
M . . . . . . . . . . . . . 6VYK6#FH-2?(<9%G!K6SBWFR)I>5?;E_
MX,M#,C:J>@PEF",8KJUW>"%H8Y)1Q."K<CCSRAZQ[ ]RJ Q5%=;5\"YY@P6P
M <!@>:BDIMG-XAQU<=B78S4V$<Q<\2ZK=7#!27#"6^0FL6Y,,<I>^N@,#]S>
M)>T-@;V+.*TU(5#6>P7#P[=WS$W78,GL"3\0-NWMKBARA3HP2+YJD_S=" E^
MT:(A9UB.$C?KUV#*S6J57W_=T LWQU\(]J:D4=_IY]P1( &R-+"=0HJRK7GY
MC7UNR)I;'JYL(VWLBP;<->I5OIVI8@]& VAL2-?8TBF:L3[Z+RP8U5Z]&5Z\
MH,=BGHG-@9WY#X+;BV)*G[-FH_!NZIN9:;Q(GPBP\9=<%)8^ZW<]!H0G0OL
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M+JH(;H&(N7.D()ZHK#(Y02[X: $+S'-(=QRMV(NJ],8. QXFV!N%%UM49-9
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M>2<70I*VA5"LN=- ,L;(]EL -A7 ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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MKKK+O'OO'OOU=]]< Y' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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& X X!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
